{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T22:29:10Z","timestamp":1787524150874,"version":"build-2736575974"},"reference-count":288,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00702-022-02522-4","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T19:02:32Z","timestamp":1655751752000},"page":"977-999","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Morphological basis of Parkinson disease-associated cognitive impairment: an update"],"prefix":"10.1007","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9641-7649","authenticated-orcid":false,"given":"Kurt A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"key":"2522_CR1","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/ana.20635","volume":"58","author":"D Aarsland","year":"2005","unstructured":"Aarsland D, Perry R, Brown A, Larsen JP, Ballard C (2005a) Neuropathology of dementia in Parkinson\u2019s disease: a prospective, community-based study. Ann Neurol 58:773\u2013776","journal-title":"Ann Neurol"},{"key":"2522_CR2","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/mds.20527","volume":"20","author":"D Aarsland","year":"2005","unstructured":"Aarsland D, Zaccai J, Brayne C (2005b) A systematic review of prevalence studies of dementia in Parkinson\u2019s disease. Mov Disord 20:1255\u20131263","journal-title":"Mov Disord"},{"key":"2522_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D (2021) Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 7:47","journal-title":"Nat Rev Dis Primers"},{"key":"2522_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.102111","volume":"25","author":"N Abbasi","year":"2020","unstructured":"Abbasi N, Fereshtehnejad SM, Zeighami Y, Larcher KM, Postuma RB, Dagher A (2020) Predicting severity and prognosis in Parkinson\u2019s disease from brain microstructure and connectivity. Neuroimage Clin 25:102111","journal-title":"Neuroimage Clin"},{"key":"2522_CR5","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1523\/JNEUROSCI.3047-16.2016","volume":"37","author":"DH Adamowicz","year":"2017","unstructured":"Adamowicz DH, Roy S, Salmon DP, Galasko DR, Hansen LA, Masliah E, Gage FH (2017) Hippocampal alpha-synuclein in dementia with lewy bodies contributes to memory impairment and is consistent with spread of pathology. J Neurosci 37:1675\u20131684","journal-title":"J Neurosci"},{"key":"2522_CR6","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s00401-010-0757-z","volume":"120","author":"CH Adler","year":"2010","unstructured":"Adler CH, Beach TG (2010) Variability of diffuse plaques and amyloid angiopathy in Parkinson\u2019s disease with mild cognitive impairment. Acta Neuropathol 120:831\u2013832","journal-title":"Acta Neuropathol"},{"key":"2522_CR7","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00401-010-0744-4","volume":"120","author":"CH Adler","year":"2010","unstructured":"Adler CH, Caviness JN, Sabbagh MN, Shill HA, Connor DJ, Sue L, Evidente VG, Driver-Dunckley E, Beach TG (2010) Heterogeneous neuropathological findings in Parkinson\u2019s disease with mild cognitive impairment. Acta Neuropathol 120:827\u2013828","journal-title":"Acta Neuropathol"},{"key":"2522_CR8","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1002\/hbm.22302","volume":"35","author":"F Agosta","year":"2014","unstructured":"Agosta F, Canu E, Stefanova E, Sarro L, Tomic A, \u0160pica V, Comi G, Kostic VS, Filippi M (2014) Mild cognitive impairment in Parkinson\u2019s disease is associated with a distributed pattern of brain white matter damage. Hum Brain Mapp 35:1921\u20131929","journal-title":"Hum Brain Mapp"},{"key":"2522_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/mdc3.12290","volume":"3","author":"RS Akhtar","year":"2016","unstructured":"Akhtar RS, Xie SX, Brennan L, Pontecorvo MJ, Hurtig HI, Trojanowski JQ, Weintraub D, Siderowf AD (2016) Amyloid-beta positron emission tomography imaging of Alzheimer\u2019s pathology in Parkinson\u2019s disease dementia. Mov Disord Clin Pract 3:367\u2013375","journal-title":"Mov Disord Clin Pract"},{"key":"2522_CR10","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/mds.28984","volume":"37","author":"OM Alzghool","year":"2022","unstructured":"Alzghool OM, van Dongen G, van de Giessen E, Schoonmade L, Beaino W (2022) Alpha-synuclein radiotracer development and in vivo imaging: recent advancements and new perspectives. Mov Disord 37:936\u2013948","journal-title":"Mov Disord"},{"key":"2522_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/archneur.59.1.102","volume":"59","author":"H Apaydin","year":"2002","unstructured":"Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW (2002) Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 59:102\u2013112","journal-title":"Arch Neurol"},{"key":"2522_CR12","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/j.neurobiolaging.2011.06.014","volume":"33","author":"L Apostolova","year":"2012","unstructured":"Apostolova L, Alves G, Hwang KS, Babakchanian S, Bronnick KS, Larsen JP, Thompson PM, Chou YY, Tysnes OB, Vefring HK, Beyer MK (2012) Hippocampal and ventricular changes in Parkinson\u2019s disease mild cognitive impairment. Neurobiol Aging 33:2113\u20132124","journal-title":"Neurobiol Aging"},{"key":"2522_CR13","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1002\/hbm.24593","volume":"40","author":"I Aracil-Bola\u00f1os","year":"2019","unstructured":"Aracil-Bola\u00f1os I, Sampedro F, Mar\u00edn-Lahoz J, Horta-Barba A, Mart\u00ednez-Horta S, Bot\u00ed M, P\u00e9rez-P\u00e9rez J, Bejr-Kasem H, Pascual-Sedano B, Campolongo A, Izquierdo C, Gironell A, G\u00f3mez-Ans\u00f3n B, Kulisevsky J, Pagonabarraga J (2019) A divergent breakdown of neurocognitive networks in Parkinson\u2019s disease mild cognitive impairment. Hum Brain Mapp 40:3233\u20133242","journal-title":"Hum Brain Mapp"},{"key":"2522_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/hbm.22622","volume":"36","author":"HC Baggio","year":"2015","unstructured":"Baggio HC, Segura B, Sala-Llonch R, Marti MJ, Valldeoriola F, Compta Y, Tolosa E, Junque C (2015) Cognitive impairment and resting-state network connectivity in Parkinson\u2019s disease. Hum Brain Mapp 36:199\u2013212","journal-title":"Hum Brain Mapp"},{"key":"2522_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.27902","volume":"35","author":"C Baiano","year":"2020","unstructured":"Baiano C, Barone P, Trojano L, Santangelo G (2020) Prevalence and clinical aspects of mild cognitive impairment in Parkinson\u2019s disease: a meta-analysis. Mov Disord 35:45\u201354","journal-title":"Mov Disord"},{"key":"2522_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0304-3940(93)90590-H","volume":"162","author":"C Bancher","year":"1993","unstructured":"Bancher C, Braak H, Fischer P, Jellinger KA (1993) Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer\u2019s and Parkinson\u2019s disease patients. Neurosci Lett 162:179\u2013182","journal-title":"Neurosci Lett"},{"key":"2522_CR17","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1002\/mds.23919","volume":"26","author":"P Barone","year":"2011","unstructured":"Barone P, Aarsland D, Burn D, Emre M, Kulisevsky J, Weintraub D (2011) Cognitive impairment in nondemented Parkinson\u2019s disease. Mov Disord 26:2483\u20132495","journal-title":"Mov Disord"},{"issue":"260\u2013275","key":"2522_CR18","volume":"105","author":"F Bassil","year":"2020","unstructured":"Bassil F, Brown HJ, Pattabhiraman S, Iwasyk JE, Maghames CM, Meymand ES, Cox TO, Riddle DM, Zhang B, Trojanowski JQ, Lee VM (2020) Amyloid-beta (aBeta) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of lewy body disorders with aBeta pathology. Neuron 105(260\u2013275):e266","journal-title":"Neuron"},{"key":"2522_CR19","doi-asserted-by":"crossref","unstructured":"Bassil F, Meymand ES, Brown HJ, Xu H, Cox TO, Pattabhiraman S, Maghames CM, Wu Q, Zhang B, Trojanowski JQ, Lee VM. (2021) Alpha-synuclein modulates tau spreading in mouse brains. J Exp Med 218:e20192193","DOI":"10.1084\/jem.20192193"},{"key":"2522_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL 3rd, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG (2009) Unified staging system for lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613\u2013634","journal-title":"Acta Neuropathol"},{"key":"2522_CR21","doi-asserted-by":"publisher","first-page":"e904","DOI":"10.1212\/WNL.0000000000011224","volume":"96","author":"S Becker","year":"2021","unstructured":"Becker S, Granert O, Timmers M, Pilotto A, Van Nueten L, Roeben B, Salvadore G, Galpern WR, Streffer J, Scheffler K, Maetzler W, Berg D, Liepelt-Scarfone I (2021) Association of hippocampal subfields, CSF biomarkers, and cognition in patients with Parkinson disease without dementia. Neurology 96:e904\u2013e915","journal-title":"Neurology"},{"key":"2522_CR22","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","volume":"79","author":"JT Bendor","year":"2013","unstructured":"Bendor JT, Logan TP, Edwards RH (2013) The function of alpha-synuclein. Neuron 79:1044\u20131066","journal-title":"Neuron"},{"key":"2522_CR23","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/mds.25844","volume":"29","author":"D Berg","year":"2014","unstructured":"Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G (2014) Time to redefine PD? Introductory statement of the MDS task force on the definition of Parkinson\u2019s disease. Mov Disord 29:454\u2013462","journal-title":"Mov Disord"},{"key":"2522_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/mds.20704","volume":"21","author":"MK Beyer","year":"2006","unstructured":"Beyer MK, Aarsland D, Greve OJ, Larsen JP (2006) Visual rating of white matter hyperintensities in Parkinson\u2019s disease. Mov Disord 21:223\u2013229","journal-title":"Mov Disord"},{"key":"2522_CR25","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/npjparkd.2016.18","volume":"2","author":"R Biundo","year":"2016","unstructured":"Biundo R, Weis L, Antonini A (2016) Cognitive decline in Parkinson\u2019s disease: the complex picture. NPJ Parkinsons Dis 2:16018","journal-title":"NPJ Parkinsons Dis"},{"key":"2522_CR26","doi-asserted-by":"publisher","first-page":"848","DOI":"10.2967\/jnumed.111.089946","volume":"52","author":"NI Bohnen","year":"2011","unstructured":"Bohnen NI, Koeppe RA, Minoshima S, Giordani B, Albin RL, Frey KA, Kuhl DE (2011) Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. J Nucl Med 52:848\u2013855","journal-title":"J Nucl Med"},{"key":"2522_CR27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jamaneurol.2014.2757","volume":"72","author":"NI Bohnen","year":"2015","unstructured":"Bohnen NI, Albin RL, Muller ML, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Frey KA (2015) Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects. JAMA Neurol 72:194\u2013200","journal-title":"JAMA Neurol"},{"key":"2522_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11910-017-0789-z","volume":"17","author":"NI Bohnen","year":"2017","unstructured":"Bohnen NI, Muller M, Frey KA (2017) Molecular imaging and updated diagnostic criteria in lewy body dementias. Curr Neurol Neurosci Rep 17:73","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2522_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102468","volume":"28","author":"LI Boon","year":"2020","unstructured":"Boon LI, Hepp DH, Douw L, van Geenen N, Broeders TAA, Geurts JJG, Berendse HW, Schoonheim MM (2020) Functional connectivity between resting-state networks reflects decline in executive function in Parkinson\u2019s disease: a longitudinal fMRI study. Neuroimage Clin 28:102468","journal-title":"Neuroimage Clin"},{"key":"2522_CR30","doi-asserted-by":"publisher","first-page":"e2261","DOI":"10.1212\/WNL.0000000000007453","volume":"92","author":"A Bougea","year":"2019","unstructured":"Bougea A, Maraki MI, Yannakoulia M, Stamelou M, Xiromerisiou G, Kosmidis MH, Ntanasi E, Dardiotis E, Hadjigeorgiou GM, Sakka P, Anastasiou CA, Stefanis L, Scarmeas N (2019) Higher probability of prodromal Parkinson disease is related to lower cognitive performance. Neurology 92:e2261\u2013e2272","journal-title":"Neurology"},{"key":"2522_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"2522_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134","journal-title":"Cell Tissue Res"},{"key":"2522_CR33","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","volume":"64","author":"H Braak","year":"2005","unstructured":"Braak H, R\u00fcb U, Jansen Steur EN, Del Tredici K, de Vos RA (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64:1404\u20131410","journal-title":"Neurology"},{"key":"2522_CR34","doi-asserted-by":"publisher","first-page":"e1821","DOI":"10.1212\/WNL.0000000000007315","volume":"92","author":"AS Buchman","year":"2019","unstructured":"Buchman AS, Yu L, Wilson RS, Leurgans SE, Nag S, Shulman JM, Barnes LL, Schneider JA, Bennett DA (2019) Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies. Neurology 92:e1821\u2013e1830","journal-title":"Neurology"},{"key":"2522_CR35","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/brain\/awh088","volume":"127","author":"EJ Burton","year":"2004","unstructured":"Burton EJ, McKeith IG, Burn DJ, Williams ED, O\u2019Brien JT (2004) Cerebral atrophy in Parkinson\u2019s disease with and without dementia: a comparison with Alzheimer\u2019s disease, dementia with lewy bodies and controls. Brain 127:791\u2013800","journal-title":"Brain"},{"key":"2522_CR36","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/mds.20652","volume":"20","author":"EJ Burton","year":"2005","unstructured":"Burton EJ, McKeith IG, Burn DJ, O\u2019Brien JT (2005) Brain atrophy rates in Parkinson\u2019s disease with and without dementia using serial magnetic resonance imaging. Mov Disord 20:1571\u20131576","journal-title":"Mov Disord"},{"key":"2522_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117481","volume":"426","author":"A Butt","year":"2021","unstructured":"Butt A, Kamtchum-Tatuene J, Khan K, Shuaib A, Jickling GC, Miyasaki JM, Smith EE, Camicioli R (2021) White matter hyperintensities in patients with Parkinson\u2019s disease: a systematic review and meta-analysis. J Neurol Sci 426:117481","journal-title":"J Neurol Sci"},{"key":"2522_CR38","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1212\/WNL.0b013e318259e1c5","volume":"78","author":"GA Carlesimo","year":"2012","unstructured":"Carlesimo GA, Piras F, Assogna F, Pontieri FE, Caltagirone C, Spalletta G (2012) Hippocampal abnormalities and memory deficits in Parkinson disease: a multimodal imaging study. Neurology 78:1939\u20131945","journal-title":"Neurology"},{"key":"2522_CR39","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/ene.13797","volume":"26","author":"LM Chahine","year":"2019","unstructured":"Chahine LM, Dos Santos C, Fullard M, Scordia C, Weintraub D, Erus G, Rosenthal L, Davatzikos C, McMillan CT (2019) Modifiable vascular risk factors, white matter disease and cognition in early Parkinson\u2019s disease. Eur J Neurol 26:246-e218","journal-title":"Eur J Neurol"},{"key":"2522_CR40","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3233\/JPD-202190","volume":"11","author":"JM Chandler","year":"2021","unstructured":"Chandler JM, Nair R, Biglan K, Ferries EA, Munsie LM, Changamire T, Patel N (2021) Characteristics of Parkinson\u2019s disease in patients with and without cognitive impairment. J Parkinsons Dis 11:1381\u20131392","journal-title":"J Parkinsons Dis"},{"key":"2522_CR41","unstructured":"Charcot J-M. (1877) De la paralysie agitante. Oeuvres Compl\u00e9tes: Le\u00e7ons sur les maladies du syst\u00e9me nerveux. Vol 1. Paris: Bureaux du Progr\u00e9s M\u00e8dical, 1872; On Parkinson\u2019s disease. Lectures on the diseases of the nervous system. G. Sigerson, trans. London: New Sydenham Society"},{"key":"2522_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neurobiolaging.2021.08.020","volume":"109","author":"D Chariss\u00e9","year":"2022","unstructured":"Chariss\u00e9 D, Erus G, Pomponio R, Gorges M, Schmidt N, Schneider C, Liepelt-Scarfone I, Riedel O, Reetz K, Schulz JB, Berg D, Storch A, Witt K, Dodel R, Kalbe E, Kassubek J, Hilker-Roggendorf R, Baudrexel S (2022) Brain age and Alzheimer\u2019s-like atrophy are domain-specific predictors of cognitive impairment in Parkinson\u2019s disease. Neurobiol Aging 109:31\u201342","journal-title":"Neurobiol Aging"},{"key":"2522_CR43","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.ejrad.2015.04.014","volume":"84","author":"B Chen","year":"2015","unstructured":"Chen B, Fan GG, Liu H, Wang S (2015) Changes in anatomical and functional connectivity of Parkinson\u2019s disease patients according to cognitive status. Eur J Radiol 84:1318\u20131324","journal-title":"Eur J Radiol"},{"key":"2522_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226175","volume":"14","author":"F Chen","year":"2019","unstructured":"Chen F, Wu T, Luo Y, Li Z, Guan Q, Meng X, Tao W, Zhang H (2019) Amnestic mild cognitive impairment in Parkinson\u2019s disease: white matter structural changes and mechanisms. PLoS One 14:e0226175","journal-title":"PLoS One"},{"key":"2522_CR45","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neulet.2015.12.055","volume":"617","author":"FX Chen","year":"2016","unstructured":"Chen FX, Kang DZ, Chen FY, Liu Y, Wu G, Li X, Yu LH, Lin YX, Lin ZY (2016) Gray matter atrophy associated with mild cognitive impairment in Parkinson\u2019s disease. Neurosci Lett 617:160\u2013165","journal-title":"Neurosci Lett"},{"key":"2522_CR280","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.parkreldis.2022.01.002","volume":"95","author":"Huimin Chen","year":"2022","unstructured":"Chen H, Wan H, Zhang M, Wardlaw JM, Feng T, Wang Y (2022) Perivascular space in Parkinson's disease: Association with CSF amyloid\/tau and cognitive decline. Parkinsonism Relat Disord 95:70-76","journal-title":"Parkinsonism & Related Disorders"},{"key":"2522_CR46","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s11682-018-9863-7","volume":"13","author":"M Chondrogiorgi","year":"2019","unstructured":"Chondrogiorgi M, Astrakas LG, Zikou AK, Weis L, Xydis VG, Antonini A, Argyropoulou MI, Konitsiotis S (2019) Multifocal alterations of white matter accompany the transition from normal cognition to dementia in Parkinson\u2019s disease patients. Brain Imaging Behav 13:232\u2013240","journal-title":"Brain Imaging Behav"},{"key":"2522_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ana.24323","volume":"77","author":"L Christopher","year":"2015","unstructured":"Christopher L, Duff-Canning S, Koshimori Y, Segura B, Boileau I, Chen R, Lang AE, Houle S, Rusjan P, Strafella AP (2015) Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease. Ann Neurol 77:269\u2013280","journal-title":"Ann Neurol"},{"key":"2522_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.parkreldis.2020.11.013","volume":"82","author":"CY Chua","year":"2021","unstructured":"Chua CY, Koh MRE, Chia NS, Ng SY, Saffari SE, Wen MC, Chen RY, Choi X, Heng DL, Neo SX, Tay KY, Au WL, Tan EK, Tan LC, Xu Z (2021) Subjective cognitive complaints in early Parkinson\u2019s disease patients with normal cognition are associated with affective symptoms. Parkinsonism Relat Disord 82:24\u201328","journal-title":"Parkinsonism Relat Disord"},{"key":"2522_CR49","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/hbm.24398","volume":"40","author":"SJ Chung","year":"2019","unstructured":"Chung SJ, Yoo HS, Lee YH, Lee HS, Ye BS, Sohn YH, Kwon H, Lee PH (2019) Frontal atrophy as a marker for dementia conversion in Parkinson\u2019s disease with mild cognitive impairment. Hum Brain Mapp 40:3784\u20133794","journal-title":"Hum Brain Mapp"},{"key":"2522_CR50","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200152","author":"SJ Chung","year":"2022","unstructured":"Chung SJ, Kim YJ, Jung JH, Lee HS, Ye BS, Sohn YH, Jeong Y, Lee PH (2022) Association between white matter connectivity and early dementia in patients with Parkinson disease. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000200152","journal-title":"Neurology"},{"key":"2522_CR51","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1212\/WNL.49.6.1570","volume":"49","author":"A Churchyard","year":"1997","unstructured":"Churchyard A, Lees AJ (1997) The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson\u2019s disease. Neurology 49:1570\u20131576","journal-title":"Neurology"},{"key":"2522_CR52","first-page":"216","volume":"76","author":"M Colom-Cadena","year":"2017","unstructured":"Colom-Cadena M, Grau-Rivera O, Planellas L, Cerquera C, Morenas E, Helgueta S, Munoz L, Kulisevsky J, Marti MJ, Tolosa E, Clarimon J, Lleo A, Gelpi E (2017) Regional overlap of pathologies in lewy body disorders. J Neuropathol Exp Neurol 76:216\u2013224","journal-title":"J Neuropathol Exp Neurol"},{"key":"2522_CR53","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1162\/NETN_a_00027","volume":"2","author":"LM Colon-Perez","year":"2018","unstructured":"Colon-Perez LM, Tanner JJ, Couret M, Goicochea S, Mareci TH, Price CC (2018) Cognition and connectomes in nondementia idiopathic Parkinson\u2019s disease. Netw Neurosci 2:106\u2013124","journal-title":"Netw Neurosci"},{"key":"2522_CR54","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/jnnp.74.7.852","volume":"74","author":"C Colosimo","year":"2003","unstructured":"Colosimo C, Hughes AJ, Kilford L, Lees AJ (2003) Lewy body cortical involvement may not always predict dementia in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 74:852\u2013856","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2522_CR55","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/brain\/awr031","volume":"134","author":"Y Compta","year":"2011","unstructured":"Compta Y, Parkkinen L, O\u2019Sullivan SS, Vandrovcova J, Holton JL, Collins C, Lashley T, Kallis C, Williams DR, de Silva R, Lees AJ, Revesz T (2011) Lewy- and alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important? Brain 134:1493\u20131505","journal-title":"Brain"},{"key":"2522_CR56","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000354670","volume":"13","author":"Y Compta","year":"2014","unstructured":"Compta Y, Parkkinen L, Kempster P, Selikhova M, Lashley T, Holton JL, Lees AJ, Revesz T (2014) The significance of alpha-synuclein, amyloid-beta and tau pathologies in Parkinson\u2019s disease progression and related dementia. Neurodegener Dis 13:154\u2013156","journal-title":"Neurodegener Dis"},{"issue":"15 Suppl","key":"2522_CR57","doi-asserted-by":"crossref","first-page":"S10.009","DOI":"10.1212\/WNL.92.15_supplement.S10.009","volume":"92","author":"D Coughlin","year":"2019","unstructured":"Coughlin D, Phillips J, Roll E, Wolk D, Das S, Nasrallah I, Vaishnavi S, Siderowf A, Weintraub D, Shaw L, Trojanowski JQ, Grossman M, Irwin DJ, McMillan CT (2019a) Cerebrospinal fluid AD biomarkers and regional [18F]-flortaucipir uptake in lewy body disorders (abstr). Neurology 92(15 Suppl):S10.009","journal-title":"Neurology"},{"key":"2522_CR58","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ana.25392","volume":"85","author":"D Coughlin","year":"2019","unstructured":"Coughlin D, Xie SX, Liang M, Williams A, Peterson C, Weintraub D, McMillan CT, Wolk DA, Akhtar RS, Hurtig HI, Branch Coslett H, Hamilton RH, Siderowf AD, Duda JE, Rascovsky K, Lee EB, Lee VM, Grossman M, Trojanowski JQ, Irwin DJ (2019b) Cognitive and pathological influences of tau pathology in lewy body disorders. Ann Neurol 85:259\u2013271","journal-title":"Ann Neurol"},{"key":"2522_CR59","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neurobiolaging.2020.08.003","volume":"96","author":"DG Coughlin","year":"2020","unstructured":"Coughlin DG, Phillips JS, Roll E, Peterson C, Lobrovich R, Rascovsky K, Ungrady M, Wolk DA, Das S, Weintraub D, Lee EB, Trojanowski JQ, Shaw LM, Vaishnavi S, Siderowf A, Nasrallah IM, Irwin DJ, McMillan CT (2020) Multimodal in vivo and postmortem assessments of tau in lewy body disorders. Neurobiol Aging 96:137\u2013147","journal-title":"Neurobiol Aging"},{"key":"2522_CR60","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/bs.pbr.2022.01.014","volume":"269","author":"DG Coughlin","year":"2022","unstructured":"Coughlin DG, Irwin DJ (2022) Neuropathological substrates of cognition in Parkinson\u2019s disease. Prog Brain Res 269:177\u2013193","journal-title":"Prog Brain Res"},{"key":"2522_CR61","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2018.08.009","volume":"393","author":"K Daida","year":"2018","unstructured":"Daida K, Tanaka R, Yamashiro K, Ogawa T, Oyama G, Nishioka K, Shimo Y, Umemura A, Hattori N (2018) The presence of cerebral microbleeds is associated with cognitive impairment in Parkinson\u2019s disease. J Neurol Sci 393:39\u201344","journal-title":"J Neurol Sci"},{"key":"2522_CR62","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00401-022-02406-7","volume":"143","author":"L de Boni","year":"2022","unstructured":"de Boni L, Watson AH, Zaccagnini L, Wallis A, Zhelcheska K, Kim N, Sanderson J, Jiang H, Martin E, Cantlon A, Rovere M, Liu L, Sylvester M, Lashley T, Dettmer U, Jaunmuktane Z, Bartels T (2022) Brain region-specific susceptibility of lewy body pathology in synucleinopathies is governed by alpha-synuclein conformations. Acta Neuropathol 143:453\u2013469","journal-title":"Acta Neuropathol"},{"key":"2522_CR63","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1136\/jnnp-2011-301817","volume":"84","author":"K Del Tredici","year":"2013","unstructured":"Del Tredici K, Braak H (2013) Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson\u2019s disease-related dementia. J Neurol Neurosurg Psychiatry 84:774\u2013783","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2522_CR64","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/1533317512470207","volume":"28","author":"B Deng","year":"2013","unstructured":"Deng B, Zhang Y, Wang L, Peng K, Han L, Nie K, Yang H, Zhang L, Wang J (2013) Diffusion tensor imaging reveals white matter changes associated with cognitive status in patients with Parkinson\u2019s disease. Am J Alzheimers Dis Other Demen 28:154\u2013164","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"2522_CR281","doi-asserted-by":"crossref","unstructured":"Devignes Q, Bordier C, Viard R, Defebvre L, Kuchcinski G, Leentjens AFG, Lopes R, Dujardin K (2022) Resting-state functional connectivity in frontostriatal and posterior cortical subtypes in Parkinson's disease-mild cognitive impairment. Mov Disord 37:502-512","DOI":"10.1002\/mds.28888"},{"key":"2522_CR65","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I (2009a) Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol 8:1150\u20131157","journal-title":"Lancet Neurol"},{"issue":"Suppl 3","key":"2522_CR66","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1353-8020(09)70769-2","volume":"15","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Fujishiro H, Orr C, DelleDonne A, Josephs KA, Frigerio R, Burnett M, Parisi JE, Klos KJ, Ahlskog JE (2009b) Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat Disord 15(Suppl 3):S1-5","journal-title":"Parkinsonism Relat Disord"},{"key":"2522_CR67","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/ane.12375","volume":"132","author":"ME Domell\u00f6f","year":"2015","unstructured":"Domell\u00f6f ME, Ekman U, Forsgren L, Elgh E (2015) Cognitive function in the early phase of Parkinson\u2019s disease, a five-year follow-up. Acta Neurol Scand 132:79\u201388","journal-title":"Acta Neurol Scand"},{"key":"2522_CR68","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1007\/s10072-020-05034-9","volume":"42","author":"G Donzuso","year":"2021","unstructured":"Donzuso G, Monastero R, Cicero CE, Luca A, Mostile G, Giuliano L, Baschi R, Caccamo M, Gagliardo C, Palmucci S, Zappia M, Nicoletti A (2021) Neuroanatomical changes in early Parkinson\u2019s disease with mild cognitive impairment: a VBM study; the Parkinson\u2019s disease cognitive impairment study (PaCoS). Neurol Sci 42:3723\u20133731","journal-title":"Neurol Sci"},{"key":"2522_CR69","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12883-015-0403-4","volume":"15","author":"BN Dugger","year":"2015","unstructured":"Dugger BN, Davis K, Malek-Ahmadi M, Hentz JG, Sandhu S, Beach TG, Adler CH, Caselli RJ, Johnson TA, Serrano GE, Shill HA, Belden C, Driver-Dunckley E, Caviness JN, Sue LI, Jacobson S, Powell J, Sabbagh MN (2015) Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment. BMC Neurol 15:146","journal-title":"BMC Neurol"},{"key":"2522_CR70","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S1474-4422(12)70138-2","volume":"11","author":"U Ekman","year":"2012","unstructured":"Ekman U, Eriksson J, Forsgren L, Mo SJ, Riklund K, Nyberg L (2012) Functional brain activity and presynaptic dopamine uptake in patients with Parkinson\u2019s disease and mild cognitive impairment: a cross-sectional study. Lancet Neurol 11:679\u2013687","journal-title":"Lancet Neurol"},{"key":"2522_CR71","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22:1689\u20131707 (quiz 1837)","journal-title":"Mov Disord"},{"key":"2522_CR72","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/mds.26048","volume":"29","author":"AJ Espay","year":"2014","unstructured":"Espay AJ, LeWitt PA, Kaufmann H (2014) Norepinephrine deficiency in Parkinson\u2019s disease: the case for noradrenergic enhancement. Mov Disord 29:1710\u20131719","journal-title":"Mov Disord"},{"key":"2522_CR73","first-page":"1239","volume":"11","author":"TS Fan","year":"2021","unstructured":"Fan TS, Liu SC, Wu RM (2021) Alpha-synuclein and cognitive decline in Parkinson disease. Life (Basel) 11:1239","journal-title":"Life (Basel)"},{"key":"2522_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102364","volume":"28","author":"YY Fathy","year":"2020","unstructured":"Fathy YY, Hepp DH, de Jong FJ, Geurts JJG, Foncke EMJ, Berendse HW, van de Berg WDJ, Schoonheim MM (2020) Anterior insular network disconnection and cognitive impairment in Parkinson\u2019s disease. Neuroimage Clin 28:102364","journal-title":"Neuroimage Clin"},{"key":"2522_CR75","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/mds.27135","volume":"32","author":"S Fengler","year":"2017","unstructured":"Fengler S, Liepelt-Scarfone I, Brockmann K, Sch\u00e4ffer E, Berg D, Kalbe E (2017) Cognitive changes in prodromal Parkinson\u2019s disease: a review. Mov Disord 32:1655\u20131666","journal-title":"Mov Disord"},{"key":"2522_CR76","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/brain\/awm305","volume":"131","author":"I Ferrer","year":"2008","unstructured":"Ferrer I, Santpere G, van Leeuwen FW (2008) Argyrophilic grain disease. Brain 131:1416\u20131432","journal-title":"Brain"},{"key":"2522_CR77","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/mds.28228","volume":"35","author":"M Filippi","year":"2020","unstructured":"Filippi M, Canu E, Donzuso G, Stojkovic T, Basaia S, Stankovic I, Tomic A, Markovic V, Petrovic I, Stefanova E, Kostic VS, Agosta F (2020) Tracking cortical changes throughout cognitive decline in Parkinson\u2019s disease. Mov Disord 35:1987\u20131998","journal-title":"Mov Disord"},{"key":"2522_CR78","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1093\/brain\/awz192","volume":"142","author":"E Fiorenzato","year":"2019","unstructured":"Fiorenzato E, Strafella AP, Kim J, Schifano R, Weis L, Antonini A, Biundo R (2019) Dynamic functional connectivity changes associated with dementia in Parkinson\u2019s disease. Brain 142:2860\u20132872","journal-title":"Brain"},{"key":"2522_CR79","unstructured":"Foo H, Kandiah N. (2016) The role of cerebrovascular disease in Parkinson's disease related cognitive impairment. J Parkinsons Dis Alzheimer Dis 3:7 - https:\/\/www.avensonline.org\/fulltextarticles\/jpa-2376-2922x-2303-0017.html"},{"key":"2522_CR80","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nicl.2016.12.008","volume":"14","author":"H Foo","year":"2016","unstructured":"Foo H, Mak E, Chander RJ, Ng A, Au WL, Sitoh YY, Tan LC, Kandiah N (2016) Associations of hippocampal subfields in the progression of cognitive decline related to Parkinson\u2019s disease. Neuroimage Clin 14:37\u201342","journal-title":"Neuroimage Clin"},{"key":"2522_CR81","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1002\/mds.23393","volume":"25","author":"ER Foster","year":"2010","unstructured":"Foster ER, Campbell MC, Burack MA, Hartlein J, Flores HP, Cairns NJ, Hershey T, Perlmutter JS (2010) Amyloid imaging of lewy body-associated disorders. Mov Disord 25:2516\u20132523","journal-title":"Mov Disord"},{"key":"2522_CR82","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40336-015-0104-4","volume":"3","author":"KA Frey","year":"2015","unstructured":"Frey KA, Petrou M (2015) Imaging amyloidopathy in Parkinson disease and parkinsonian dementia syndromes. Clin Transl Imaging 3:57\u201364","journal-title":"Clin Transl Imaging"},{"issue":"Suppl 1","key":"2522_CR83","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/j.parkreldis.2017.07.013","volume":"46","author":"JH Friedman","year":"2018","unstructured":"Friedman JH (2018) Dementia with Lewy bodies and Parkinson disease dementia: it is the same disease! Parkinsonism Relat Disord 46(Suppl 1):S6\u2013S9","journal-title":"Parkinsonism Relat Disord"},{"key":"2522_CR84","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.parkreldis.2017.11.003","volume":"46","author":"AI Garcia-Diaz","year":"2018","unstructured":"Garcia-Diaz AI, Segura B, Baggio HC, Uribe C, Campabadal A, Abos A, Marti MJ, Valldeoriola F, Compta Y, Bargallo N, Junque C (2018) Cortical thinning correlates of changes in visuospatial and visuoperceptual performance in Parkinson\u2019s disease: A 4-year follow-up. Parkinsonism Relat Disord 46:62\u201368","journal-title":"Parkinsonism Relat Disord"},{"key":"2522_CR85","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/bpa.12474","volume":"28","author":"P Garcia-Esparcia","year":"2018","unstructured":"Garcia-Esparcia P, Koneti A, Rodr\u00edguez-Oroz MC, Gago B, Del Rio JA, Ferrer I (2018) Mitochondrial activity in the frontal cortex area 8 and angular gyrus in Parkinson\u2019s disease and Parkinson\u2019s disease with dementia. Brain Pathol 28:43\u201357","journal-title":"Brain Pathol"},{"key":"2522_CR86","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/mds.27561","volume":"34","author":"F Gargouri","year":"2019","unstructured":"Gargouri F, Gallea C, Mongin M, Pyatigorskaya N, Valabregue R, Ewenczyk C, Sarazin M, Yahia-Cherif L, Vidailhet M, Leh\u00e9ricy S (2019) Multimodal magnetic resonance imaging investigation of basal forebrain damage and cognitive deficits in Parkinson\u2019s disease. Mov Disord 34:516\u2013525","journal-title":"Mov Disord"},{"key":"2522_CR87","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/mds.26513","volume":"31","author":"AP Gatt","year":"2016","unstructured":"Gatt AP, Duncan OF, Attems J, Francis PT, Ballard CG, Bateman JM (2016) Dementia in Parkinson\u2019s disease is associated with enhanced mitochondrial complex I deficiency. Mov Disord 31:352\u2013359","journal-title":"Mov Disord"},{"issue":"Suppl 2","key":"2522_CR88","first-page":"S81","volume":"64","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Emre M, Dubois B (2008) Parkinson\u2019s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol 64(Suppl 2):S81-92","journal-title":"Ann Neurol"},{"key":"2522_CR89","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","volume":"73","author":"SN Gomperts","year":"2016","unstructured":"Gomperts SN, Locascio JJ, Makaretz SJ, Schultz A, Caso C, Vasdev N, Sperling R, Growdon JH, Dickerson BC, Johnson K (2016) Tau positron emission tomographic imaging in the lewy body diseases. JAMA Neurol 73:1334\u20131341","journal-title":"JAMA Neurol"},{"key":"2522_CR90","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1111\/j.1468-1331.2012.03682.x","volume":"19","author":"R Gonz\u00e1lez-Redondo","year":"2012","unstructured":"Gonz\u00e1lez-Redondo R, Toledo J, Clavero P, Lamet I, Garc\u00eda-Garc\u00eda D, Garc\u00eda-Eulate R, Mart\u00ednez-Lage P, Rodr\u00edguez-Oroz MC (2012) The impact of silent vascular brain burden in cognitive impairment in Parkinson\u2019s disease. Eur J Neurol 19:1100\u20131107","journal-title":"Eur J Neurol"},{"key":"2522_CR91","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1093\/brain\/awv104","volume":"138","author":"J Gratwicke","year":"2015","unstructured":"Gratwicke J, Jahanshahi M, Foltynie T (2015) Parkinson\u2019s disease dementia: a neural networks perspective. Brain 138:1454\u20131476","journal-title":"Brain"},{"key":"2522_CR92","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.parkreldis.2021.05.027","volume":"88","author":"MJ Grothe","year":"2021","unstructured":"Grothe MJ, Labrador-Espinosa MA, Jes\u00fas S, Mac\u00edas-Garc\u00eda D, Adarmes-G\u00f3mez A, Carrillo F, Camacho EI, Franco-Rosado P, Lora FR, Mart\u00edn-Rodr\u00edguez JF, Barber\u00e1 MA, Pastor P, Arroyo SE, Vila BS, Foraster AC, Mart\u00ednez JR, Padilla FC, Morlans MP, Aramburu IG, Ceberio JI, Vara JH, de F\u00e1bregues-Boixar O, de Deus FT, Pascual-Sedano B, Kulisevsky J, Mart\u00ednez-Mart\u00edn P, Santos-Garc\u00eda D, Mir P (2021) In vivo cholinergic basal forebrain degeneration and cognition in Parkinson\u2019s disease: Imaging results from the COPPADIS study. Parkinsonism Relat Disord 88:68\u201375","journal-title":"Parkinsonism Relat Disord"},{"key":"2522_CR93","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/mds.28886","volume":"37","author":"T Guttuso Jr","year":"2022","unstructured":"Guttuso T Jr, Sirica D, Tosun D, Zivadinov R, Pasternak O, Weintraub D, Baglio F, Bergsland N (2022) Thalamic dorsomedial nucleus free water correlates with cognitive decline in Parkinson\u2019s disease. Mov Disord 37:490\u2013501","journal-title":"Mov Disord"},{"key":"2522_CR94","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/brain\/awu193","volume":"137","author":"H Hall","year":"2014","unstructured":"Hall H, Reyes S, Landeck N, Bye C, Leanza G, Double K, Thompson L, Halliday G, Kirik D (2014) Hippocampal lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson\u2019s disease. Brain 137:2493\u20132508","journal-title":"Brain"},{"key":"2522_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.irn.2018.09.009","volume":"144","author":"JM Hall","year":"2019","unstructured":"Hall JM, Lewis SJG (2019) Neural correlates of cognitive impairment in Parkinson\u2019s disease: a review of structural MRI findings. Int Rev Neurobiol 144:1\u201328","journal-title":"Int Rev Neurobiol"},{"key":"2522_CR96","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00702-011-0641-6","volume":"118","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Song YJ, Harding AJ (2011) Striatal beta-amyloid in dementia with lewy bodies but not Parkinson\u2019s disease. J Neural Transm (vienna) 118:713\u2013719","journal-title":"J Neural Transm (vienna)"},{"key":"2522_CR97","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/mds.25857","volume":"29","author":"GM Halliday","year":"2014","unstructured":"Halliday GM, Leverenz JB, Schneider JS, Adler CH (2014) The neurobiological basis of cognitive impairment in Parkinson\u2019s disease. Mov Disord 29:634\u2013650","journal-title":"Mov Disord"},{"key":"2522_CR98","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1007\/s00415-014-7403-y","volume":"261","author":"JH Ham","year":"2014","unstructured":"Ham JH, Yi H, Sunwoo MK, Hong JY, Sohn YH, Lee PH (2014) Cerebral microbleeds in patients with Parkinson\u2019s disease. J Neurol 261:1628\u20131635","journal-title":"J Neurol"},{"key":"2522_CR99","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/brain\/awu036","volume":"137","author":"A Hanganu","year":"2014","unstructured":"Hanganu A, Bedetti C, Degroot C, Mejia-Constain B, Lafontaine AL, Soland V, Chouinard S, Bruneau MA, Mellah S, Belleville S, Monchi O (2014) Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson\u2019s disease longitudinally. Brain 137:1120\u20131129","journal-title":"Brain"},{"key":"2522_CR100","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.parkreldis.2019.10.016","volume":"69","author":"U Hanning","year":"2019","unstructured":"Hanning U, Teuber A, Lang E, Trenkwalder C, Mollenhauer B, Minnerup H (2019) White matter hyperintensities are not associated with cognitive decline in early Parkinson\u2019s disease\u2014the DeNopa cohort. Parkinsonism Relat Disord 69:61\u201367","journal-title":"Parkinsonism Relat Disord"},{"key":"2522_CR101","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3233\/JPD-191774","volume":"10","author":"AK Hansen","year":"2020","unstructured":"Hansen AK, Parbo P, Ismail R, \u00d8stergaard K, Brooks DJ, Borghammer P (2020) Tau tangles in Parkinson\u2019s disease: a 2-year follow-up flortaucipir PET study. J Parkinsons Dis 10:161\u2013171","journal-title":"J Parkinsons Dis"},{"key":"2522_CR102","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s004010100390","volume":"102","author":"AJ Harding","year":"2001","unstructured":"Harding AJ, Halliday GM (2001) Cortical lewy body pathology in the diagnosis of dementia. Acta Neuropathol 102:355\u2013363","journal-title":"Acta Neuropathol"},{"key":"2522_CR103","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/brain\/awf033","volume":"125","author":"AJ Harding","year":"2002","unstructured":"Harding AJ, Broe GA, Halliday GM (2002) Visual hallucinations in lewy body disease relate to lewy bodies in the temporal lobe. Brain 125:391\u2013403","journal-title":"Brain"},{"key":"2522_CR104","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/hbm.21245","volume":"33","author":"T Hattori","year":"2012","unstructured":"Hattori T, Orimo S, Aoki S, Ito K, Abe O, Amano A, Sato R, Sakai K, Mizusawa H (2012) Cognitive status correlates with white matter alteration in Parkinson\u2019s disease. Hum Brain Mapp 33:727\u2013739","journal-title":"Hum Brain Mapp"},{"key":"2522_CR105","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1600-0404.2005.00389.x","volume":"112","author":"K Haugarvoll","year":"2005","unstructured":"Haugarvoll K, Aarsland D, Wentzel-Larsen T, Larsen JP (2005) The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson\u2019s disease. Acta Neurol Scand 112:386\u2013390","journal-title":"Acta Neurol Scand"},{"key":"2522_CR106","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.27802","volume":"34","author":"S Heinzel","year":"2019","unstructured":"Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB (2019) Update of the MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord 34:1464\u20131470","journal-title":"Mov Disord"},{"key":"2522_CR107","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord 23:837\u2013844","journal-title":"Mov Disord"},{"key":"2522_CR108","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s40478-019-0836-x","volume":"7","author":"MX Henderson","year":"2019","unstructured":"Henderson MX, Sengupta M, Trojanowski JQ, Lee VMY (2019) Alzheimer\u2019s disease tau is a prominent pathology in LRRK2 Parkinson\u2019s disease. Acta Neuropathol Commun 7:183","journal-title":"Acta Neuropathol Commun"},{"key":"2522_CR109","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/jnen\/nlw070","volume":"75","author":"DH Hepp","year":"2016","unstructured":"Hepp DH, Vergoossen DL, Huisman E, Lemstra AW, Berendse HW, Rozemuller AJ, Foncke EM, van de Berg WD (2016) Distribution and load of amyloid-beta pathology in Parkinson disease and dementia with Lewy bodies. J Neuropathol Exp Neurol 75:936\u2013945","journal-title":"J Neuropathol Exp Neurol"},{"key":"2522_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2013.08.010","volume":"20","author":"JV Hindle","year":"2014","unstructured":"Hindle JV, Martyr A, Clare L (2014) Cognitive reserve in Parkinson\u2019s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 20:1\u20137","journal-title":"Parkinsonism Relat Disord"},{"key":"2522_CR111","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1136\/jnnp-2011-301818","volume":"83","author":"S Hirano","year":"2012","unstructured":"Hirano S, Shinotoh H, Eidelberg D (2012) Functional brain imaging of cognitive dysfunction in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 83:963\u2013969","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2522_CR112","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/neup.12208","volume":"35","author":"T Homma","year":"2015","unstructured":"Homma T, Mochizuki Y, Takahashi K, Komori T (2015) Medial temporal regional argyrophilic grain as a possible important factor affecting dementia in Parkinson\u2019s disease. Neuropathology 35:441\u2013451","journal-title":"Neuropathology"},{"key":"2522_CR113","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1007\/s00415-011-6404-3","volume":"259","author":"JY Hong","year":"2012","unstructured":"Hong JY, Lee JE, Sohn YH, Lee PH (2012) Neurocognitive and atrophic patterns in Parkinson\u2019s disease based on subjective memory complaints. J Neurol 259:1706\u20131712","journal-title":"J Neurol"},{"key":"2522_CR114","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/mds.27002","volume":"32","author":"J Hoogland","year":"2017","unstructured":"Hoogland J, Boel JA, de Bie RMA, Geskus RB, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Tr\u00f6ster AI, Burn DJ, Litvan I, Geurtsen GJ (2017) Mild cognitive impairment as a risk factor for Parkinson\u2019s disease dementia. Mov Disord 32:1056\u20131065","journal-title":"Mov Disord"},{"key":"2522_CR115","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.parkreldis.2013.05.010","volume":"19","author":"J Horvath","year":"2013","unstructured":"Horvath J, Herrmann FR, Burkhard PR, Bouras C, K\u00f6vari E (2013) Neuropathology of dementia in a large cohort of patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 19:864\u2013868 (Discussion 864)","journal-title":"Parkinsonism Relat Disord"},{"key":"2522_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.788846","volume":"14","author":"Y Hou","year":"2022","unstructured":"Hou Y, Shang H (2022) Magnetic resonance imaging markers for cognitive impairment in Parkinson\u2019s disease: current view. Front Aging Neurosci 14:788846","journal-title":"Front Aging Neurosci"},{"key":"2522_CR117","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/bpa.12182","volume":"25","author":"DR Howlett","year":"2015","unstructured":"Howlett DR, Whitfield D, Johnson M, Attems J, O\u2019Brien JT, Aarsland D, Lai MK, Lee JH, Chen C, Ballard C, Hortobagyi T, Francis PT (2015) Regional multiple pathology scores are associated with cognitive decline in lewy body dementias. Brain Pathol 25:401\u2013408","journal-title":"Brain Pathol"},{"key":"2522_CR118","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.neuroimage.2006.09.003","volume":"34","author":"C Huang","year":"2007","unstructured":"Huang C, Mattis P, Tang C, Perrine K, Carbon M, Eidelberg D (2007) Metabolic brain networks associated with cognitive function in Parkinson\u2019s disease. Neuroimage 34:714\u2013723","journal-title":"Neuroimage"},{"key":"2522_CR119","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1212\/01.wnl.0000304050.05332.9c","volume":"70","author":"C Huang","year":"2008","unstructured":"Huang C, Mattis P, Perrine K, Brown N, Dhawan V, Eidelberg D (2008) Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology 70:1470\u20131477","journal-title":"Neurology"},{"key":"2522_CR120","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.parkreldis.2020.11.010","volume":"82","author":"A Inguanzo","year":"2021","unstructured":"Inguanzo A, Sala-Llonch R, Segura B, Erostarbe H, Abos A, Campabadal A, Uribe C, Baggio HC, Compta Y, Marti MJ, Valldeoriola F, Bargallo N, Junque C (2021) Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson\u2019s disease. Parkinsonism Relat Disord 82:16\u201323","journal-title":"Parkinsonism Relat Disord"},{"key":"2522_CR121","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ana.23659","volume":"72","author":"DJ Irwin","year":"2012","unstructured":"Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, Van Deerlin V, Lee VM, Leverenz JB, Montine TJ, Duda JE, Hurtig HI, Trojanowski JQ (2012) Neuropathologic substrates of Parkinson disease dementia. Ann Neurol 72:587\u2013598","journal-title":"Ann Neurol"},{"key":"2522_CR122","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549","volume":"14","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Lee VM, Trojanowski JQ (2013) Parkinsons disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies. Nat Rev Neurosci 14:626\u2013636","journal-title":"Nat Rev Neurosci"},{"key":"2522_CR123","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK, Nelson PT, Jicha GA, Woltjer R, Quinn JF, Kaye J, Leverenz JB, Tsuang D, Longfellow K, Yearout D, Kukull W, Keene CD, Montine TJ, Zabetian CP, Trojanowski JQ (2017) Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 16:55\u201365","journal-title":"Lancet Neurol"},{"key":"2522_CR124","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1749-6632.1991.tb00218.x","volume":"640","author":"K Jellinger","year":"1991","unstructured":"Jellinger K, Braak H, Braak E, Fischer P (1991) Alzheimer lesions in the entorhinal region and isocortex in Parkinson\u2019s and Alzheimer\u2019s diseases. Ann NY Acad Sci 640:203\u2013209","journal-title":"Ann NY Acad Sci"},{"key":"2522_CR125","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s007020200027","volume":"109","author":"KA Jellinger","year":"2002","unstructured":"Jellinger KA, Seppi K, Wenning GK, Poewe W (2002) Impact of coexistent Alzheimer pathology on the natural history of Parkinson\u2019s disease. J Neural Transm 109:329\u2013339","journal-title":"J Neural Transm"},{"key":"2522_CR126","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00401-006-0088-2","volume":"112","author":"KA Jellinger","year":"2006","unstructured":"Jellinger KA, Attems J (2006) Does striatal pathology distinguish Parkinson disease with dementia and dementia with lewy bodies? Acta Neuropathol 112:253\u2013260","journal-title":"Acta Neuropathol"},{"key":"2522_CR127","first-page":"270","volume-title":"Degenerative diseases of the nervous system","author":"KA Jellinger","year":"2007","unstructured":"Jellinger KA (2007) Lewy body disorders. In: Youdim MBH, Riederer P, Mandel SA, Battistin L, Lajtha A (eds) Degenerative diseases of the nervous system. Springer Science, New York, pp 270\u2013343"},{"key":"2522_CR128","doi-asserted-by":"crossref","unstructured":"Jellinger KA. (2007b) Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study. J Neural Transm Suppl 72:91\u2013104","DOI":"10.1007\/978-3-211-73574-9_12"},{"key":"2522_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-008-0406-y","volume":"116","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA (2008) A critical reappraisal of current staging of lewy-related pathology in human brain. Acta Neuropathol 116:1\u201316","journal-title":"Acta Neuropathol"},{"key":"2522_CR130","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00401-008-0347-5","volume":"115","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA, Attems J (2008) Prevalence and impact of vascular and Alzheimer pathologies in lewy body disease. Acta Neuropathol 115:427\u2013436","journal-title":"Acta Neuropathol"},{"key":"2522_CR131","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000197890","volume":"24","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA (2009) Significance of brain lesions in Parkinson disease dementia and lewy body dementia. Front Neurol Neurosci 24:114\u2013125","journal-title":"Front Neurol Neurosci"},{"key":"2522_CR132","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00401-010-0755-1","volume":"120","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA (2010) Neuropathology in Parkinson\u2019s disease with mild cognitive impairment. Acta Neuropathol 120:829\u2013830 (Author reply 831)","journal-title":"Acta Neuropathol"},{"key":"2522_CR133","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000285518","volume":"7","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA (2010b) Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases. Neurodegener Dis 7:112\u2013115","journal-title":"Neurodegener Dis"},{"key":"2522_CR134","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.expneurol.2010.10.006","volume":"227","author":"KA Jellinger","year":"2011","unstructured":"Jellinger KA (2011) Interaction between alpha-synuclein and tau in Parkinson\u2019s disease comment on Wills et al.: elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson\u2019s disease brains with and without dementia. Exp Neurol 227:13\u201318 (Exp Neurol 2010; 225: 210-218)","journal-title":"Exp Neurol"},{"key":"2522_CR135","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mds.23795","volume":"27","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012a) Neuropathology of sporadic Parkinson\u2019s disease: evaluation and changes of concepts. Mov Disord 27:8\u201330","journal-title":"Mov Disord"},{"key":"2522_CR136","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1586\/ern.12.131","volume":"12","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012b) Neurobiology of cognitive impairment in Parkinson\u2019s disease. Expert Rev Neurother 12:1451\u20131466","journal-title":"Expert Rev Neurother"},{"key":"2522_CR137","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00702-012-0771-5","volume":"120","author":"KA Jellinger","year":"2013","unstructured":"Jellinger KA (2013) Mild cognitive impairment in Parkinson disease: heterogenous mechanisms. J Neural Transm (Vienna) 120:157\u2013167","journal-title":"J Neural Transm (Vienna)"},{"key":"2522_CR138","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00702-017-1821-9","volume":"125","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA (2018) Dementia with lewy bodies and Parkinson\u2019s disease-dementia: current concepts and controversies. J Neural Transm (Vienna) 125:615\u2013650","journal-title":"J Neural Transm (Vienna)"},{"key":"2522_CR139","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12916-018-1016-8","volume":"16","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA, Korczyn AD (2018) Are dementia with lewy bodies and Parkinson\u2019s disease dementia the same disease? BMC Med 16:34","journal-title":"BMC Med"},{"key":"2522_CR282","doi-asserted-by":"crossref","unstructured":"Jeong SH, Lee HS, Jung JH, Baik K, Sohn YH, Chung SJ, Lee PH (2022) Associations between white matter hyperintensities, striatal dopamine loss, and cognition in drug-naive Parkinson's disease. Parkinsonism Relat Disord 97:1-7","DOI":"10.1016\/j.parkreldis.2022.02.020"},{"key":"2522_CR140","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"F Jessen","year":"2014","unstructured":"Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Ch\u00e9telat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM, Glodzik L, van Harten AC, de Leon MJ, McHugh P, Mielke MM, Molinuevo JL, Mosconi L, Osorio RS, Perrotin A, Petersen RC, Rabin LA, Rami L, Reisberg B, Rentz DM, Sachdev PS, de la Sayette V, Saykin AJ, Scheltens P, Shulman MB, Slavin MJ, Sperling RA, Stewart R, Uspenskaya O, Vellas B, Visser PJ, Wagner M (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimers Dement 10:844\u2013852","journal-title":"Alzheimers Dement"},{"key":"2522_CR141","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.14336\/AD.2018.1116","volume":"10","author":"X Jia","year":"2019","unstructured":"Jia X, Wang Z, Yang T, Li Y, Gao S, Wu G, Jiang T, Liang P (2019) Entorhinal cortex atrophy in early, drug-naive Parkinson\u2019s disease with mild cognitive impairment. Aging Dis 10:1221\u20131232","journal-title":"Aging Dis"},{"key":"2522_CR142","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/hipo.20212","volume":"16","author":"FC Joelving","year":"2006","unstructured":"Joelving FC, Billeskov R, Christensen JR, West M, Pakkenberg B (2006) Hippocampal neuron and glial cell numbers in Parkinson\u2019s disease\u2014a stereological study. Hippocampus 16:826\u2013833","journal-title":"Hippocampus"},{"key":"2522_CR143","doi-asserted-by":"publisher","first-page":"16021","DOI":"10.1038\/s41598-021-95638-8","volume":"11","author":"LE Jonkman","year":"2021","unstructured":"Jonkman LE, Fathy YY, Berendse HW, Schoonheim MM, van de Berg WDJ (2021) Structural network topology and microstructural alterations of the anterior insula associate with cognitive and affective impairment in Parkinson\u2019s disease. Sci Rep 11:16021","journal-title":"Sci Rep"},{"key":"2522_CR144","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00401-009-0597-x","volume":"118","author":"ME Kalaitzakis","year":"2009","unstructured":"Kalaitzakis ME, Pearce RK (2009) The morbid anatomy of dementia in Parkinson\u2019s disease. Acta Neuropathol 118:587\u2013598","journal-title":"Acta Neuropathol"},{"key":"2522_CR145","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3174\/ajnr.A2860","volume":"33","author":"K Kamagata","year":"2012","unstructured":"Kamagata K, Motoi Y, Abe O, Shimoji K, Hori M, Nakanishi A, Sano T, Kuwatsuru R, Aoki S, Hattori N (2012) White matter alteration of the cingulum in Parkinson disease with and without dementia: evaluation by diffusion tensor tract-specific analysis. AJNR Am J Neuroradiol 33:890\u2013895","journal-title":"AJNR Am J Neuroradiol"},{"key":"2522_CR146","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1007\/s00330-013-2775-4","volume":"23","author":"K Kamagata","year":"2013","unstructured":"Kamagata K, Motoi Y, Tomiyama H, Abe O, Ito K, Shimoji K, Suzuki M, Hori M, Nakanishi A, Sano T, Kuwatsuru R, Sasai K, Aoki S, Hattori N (2013) Relationship between cognitive impairment and white-matter alteration in Parkinson\u2019s disease with dementia: tract-based spatial statistics and tract-specific analysis. Eur Radiol 23:1946\u20131955","journal-title":"Eur Radiol"},{"key":"2522_CR147","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ana.24825","volume":"81","author":"K Kantarci","year":"2017","unstructured":"Kantarci K, Lowe VJ, Boeve BF, Senjem ML, Tosakulwong N, Lesnick TG, Spychalla AJ, Gunter JL, Fields JA, Graff-Radford J, Ferman TJ, Jones DT, Murray ME, Knopman DS, Jack CR Jr, Petersen RC (2017) AV-1451 tau and beta-amyloid positron emission tomography imaging in dementia with lewy bodies. Ann Neurol 81:58\u201367","journal-title":"Ann Neurol"},{"key":"2522_CR148","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/brain\/awq059","volume":"133","author":"PA Kempster","year":"2010","unstructured":"Kempster PA, O\u2019Sullivan SS, Holton JL, Revesz T, Lees AJ (2010) Relationships between age and late progression of Parkinson\u2019s disease: a clinico-pathological study. Brain 133:1755\u20131762","journal-title":"Brain"},{"key":"2522_CR149","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s00415-013-7018-8","volume":"260","author":"M Kiesmann","year":"2013","unstructured":"Kiesmann M, Chanson JB, Godet J, Vogel T, Schweiger L, Chayer S, Kaltenbach G (2013) The movement disorders society criteria for the diagnosis of Parkinson\u2019s disease dementia: their usefulness and limitations in elderly patients. J Neurol 260:2569\u20132579","journal-title":"J Neurol"},{"key":"2522_CR150","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3233\/JAD-160597","volume":"55","author":"Y Kim","year":"2017","unstructured":"Kim Y, Lee D, Cho KH, Lee JJ, Ham JH, Ye BS, Lee SK, Lee JM, Sohn YH, Lee PH (2017) Cognitive and neuroanatomical correlates in early versus late onset Parkinson\u2019s disease dementia. J Alzheimers Dis 55:485\u2013495","journal-title":"J Alzheimers Dis"},{"key":"2522_CR151","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/mds.27991","volume":"35","author":"MG Knox","year":"2020","unstructured":"Knox MG, Adler CH, Shill HA, Driver-Dunckley E, Mehta SA, Belden C, Zamrini E, Serrano G, Sabbagh MN, Caviness JN, Sue LI, Davis KJ, Dugger BN, Beach TG (2020) Neuropathological findings in Parkinson\u2019s disease with mild cognitive impairment. Mov Disord 35:845\u2013850","journal-title":"Mov Disord"},{"key":"2522_CR152","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neurobiolaging.2017.08.020","volume":"60","author":"JH Ko","year":"2017","unstructured":"Ko JH, Katako A, Aljuaid M, Goertzen AL, Borys A, Hobson DE, Kim SM, Lee CS (2017) Distinct brain metabolic patterns separately associated with cognition, motor function, and aging in Parkinson\u2019s disease dementia. Neurobiol Aging 60:81\u201391","journal-title":"Neurobiol Aging"},{"key":"2522_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.120015","volume":"433","author":"C Koros","year":"2022","unstructured":"Koros C, Stefanis L, Scarmeas N (2022) Parkinsonism and dementia. J Neurol Sci 433:120015","journal-title":"J Neurol Sci"},{"key":"2522_CR154","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/archneurol.2012.1608","volume":"69","author":"PT Kotzbauer","year":"2012","unstructured":"Kotzbauer PT, Cairns NJ, Campbell MC, Willis AW, Racette BA, Tabbal SD, Perlmutter JS (2012) Pathologic accumulation of alpha-synuclein and abeta in Parkinson disease patients with dementia. Arch Neurol 69:1326\u20131331","journal-title":"Arch Neurol"},{"key":"2522_CR155","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s40478-020-01083-5","volume":"8","author":"A Kouli","year":"2020","unstructured":"Kouli A, Camacho M, Allinson K, Williams-Gray CH (2020) Neuroinflammation and protein pathology in Parkinson\u2019s disease dementia. Acta Neuropathol Commun 8:211","journal-title":"Acta Neuropathol Commun"},{"key":"2522_CR156","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00401-003-0705-2","volume":"106","author":"E K\u00f6vari","year":"2003","unstructured":"K\u00f6vari E, Gold G, Herrmann FR, Canuto A, Hof PR, Bouras C, Giannakopoulos P (2003) Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson\u2019s disease. Acta Neuropathol 106:83\u201388","journal-title":"Acta Neuropathol"},{"key":"2522_CR157","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1212\/01.WNL.0000165987.89198.65","volume":"64","author":"ML Kraybill","year":"2005","unstructured":"Kraybill ML, Larson EB, Tsuang DW, Teri L, McCormick WC, Bowen JD, Kukull WA, Leverenz JB, Cherrier MM (2005) Cognitive differences in dementia patients with autopsy-verified AD, lewy body pathology, or both. Neurology 64:2069\u20132073","journal-title":"Neurology"},{"key":"2522_CR158","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s10548-018-0675-2","volume":"32","author":"J Kunst","year":"2019","unstructured":"Kunst J, Marecek R, Klobusiakova P, Balazova Z, Anderkova L, Nemcova-Elfmarkova N, Rektorova I (2019) Patterns of grey matter atrophy at different stages of Parkinson\u2019s and Alzheimer\u2019s diseases and relation to cognition. Brain Topogr 32:142\u2013160","journal-title":"Brain Topogr"},{"key":"2522_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102252","volume":"26","author":"S Lang","year":"2020","unstructured":"Lang S, Yoon EJ, Kibreab M, Kathol I, Cheetham J, Hammer T, Sarna J, Ismail Z, Monchi O (2020) Mild behavioral impairment in Parkinson\u2019s disease is associated with altered corticostriatal connectivity. Neuroimage Clin 26:102252","journal-title":"Neuroimage Clin"},{"key":"2522_CR160","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-007-0336-0","volume":"115","author":"T Lashley","year":"2008","unstructured":"Lashley T, Holton JL, Gray E, Kirkham K, O\u2019Sullivan SS, Hilbig A, Wood NW, Lees AJ, Revesz T (2008) Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson\u2019s disease patients. Acta Neuropathol 115:417\u2013425","journal-title":"Acta Neuropathol"},{"key":"2522_CR161","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fnsys.2014.00045","volume":"8","author":"AV Lebedev","year":"2014","unstructured":"Lebedev AV, Westman E, Simmons A, Lebedeva A, Siepel FJ, Pereira JB, Aarsland D (2014) Large-scale resting state network correlates of cognitive impairment in Parkinson\u2019s disease and related dopaminergic deficits. Front Syst Neurosci 8:45","journal-title":"Front Syst Neurosci"},{"key":"2522_CR162","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/WAD.0b013e3181d71a13","volume":"24","author":"SJ Lee","year":"2010","unstructured":"Lee SJ, Kim JS, Yoo JY, Song IU, Kim BS, Jung SL, Yang DW, Kim YI, Jeong DS, Lee KS (2010) Influence of white matter hyperintensities on the cognition of patients with Parkinson disease. Alzheimer Dis Assoc Disord 24:227\u2013233","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2522_CR163","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/0891988712464823","volume":"25","author":"I Leroi","year":"2012","unstructured":"Leroi I, McDonald K, Pantula H, Harbishettar V (2012) Cognitive impairment in Parkinson disease: impact on quality of life, disability, and caregiver burden. J Geriatr Psychiatry Neurol 25:208\u2013214","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"2522_CR164","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/mds.27682","volume":"34","author":"Y Li","year":"2019","unstructured":"Li Y, Wang C, Wang J, Zhou Y, Ye F, Zhang Y, Cheng X, Huang Z, Liu K, Fei G, Zhong C, Zeng M, Jin L (2019) Mild cognitive impairment in de novo Parkinson\u2019s disease: a neuromelanin MRI study in locus coeruleus. Mov Disord 34:884\u2013892","journal-title":"Mov Disord"},{"key":"2522_CR165","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.parkreldis.2009.02.003","volume":"15","author":"LS Libow","year":"2009","unstructured":"Libow LS, Frisina PG, Haroutunian V, Perl DP, Purohit DP (2009) Parkinson\u2019s disease dementia: a diminished role for the lewy body. Parkinsonism Relat Disord 15:572\u2013575","journal-title":"Parkinsonism Relat Disord"},{"key":"2522_CR166","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan I, Goldman JG, Tr\u00f6ster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: movement disorder society task force guidelines. Mov Disord 27:349\u2013356","journal-title":"Mov Disord"},{"key":"2522_CR167","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/nan.12513","volume":"44","author":"AKL Liu","year":"2018","unstructured":"Liu AKL, Lim EJ, Ahmed I, Chang RC, Pearce RKB, Gentleman SM (2018) Review: revisiting the human cholinergic nucleus of the diagonal band of broca. Neuropathol Appl Neurobiol 44:647\u2013662","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2522_CR168","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40478-019-0717-3","volume":"7","author":"AKL Liu","year":"2019","unstructured":"Liu AKL, Chau TW, Lim EJ, Ahmed I, Chang RC, Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RKB (2019) Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson\u2019s disease with cognitive decline. Acta Neuropathol Commun 7:61","journal-title":"Acta Neuropathol Commun"},{"key":"2522_CR169","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1002\/acn3.51429","volume":"8","author":"H Liu","year":"2021","unstructured":"Liu H, Deng B, Xie F, Yang X, Xie Z, Chen Y, Yang Z, Huang X, Zhu S, Wang Q (2021) The influence of white matter hyperintensity on cognitive impairment in Parkinson\u2019s disease. Ann Clin Transl Neurol 8:1917\u20131934","journal-title":"Ann Clin Transl Neurol"},{"key":"2522_CR170","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/jon.12230","volume":"25","author":"E Mak","year":"2015","unstructured":"Mak E, Dwyer MG, Ramasamy DP, Au WL, Tan LC, Zivadinov R, Kandiah N (2015) White matter hyperintensities and mild cognitive impairment in Parkinson\u2019s disease. J Neuroimaging 25:754\u2013760","journal-title":"J Neuroimaging"},{"key":"2522_CR171","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/mds.26698","volume":"31","author":"N Malek","year":"2016","unstructured":"Malek N, Lawton MA, Swallow DM, Grosset KA, Marrinan SL, Bajaj N, Barker RA, Burn DJ, Hardy J, Morris HR, Williams NM, Wood N, Ben-Shlomo Y, Grosset DG (2016) Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson\u2019s disease. Mov Disord 31:1518\u20131526","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"2522_CR172","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1002\/mds.22787","volume":"25","author":"K Marder","year":"2010","unstructured":"Marder K (2010) Cognitive impairment and dementia in Parkinson\u2019s disease. Mov Disord 25(Suppl 1):S110-116","journal-title":"Mov Disord"},{"key":"2522_CR173","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3233\/JAD-2010-1220","volume":"19","author":"WR Markesbery","year":"2010","unstructured":"Markesbery WR (2010) Neuropathologic alterations in mild cognitive impairment: a review. J Alzheimers Dis 19:221\u2013228","journal-title":"J Alzheimers Dis"},{"key":"2522_CR174","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40478-017-0482-0","volume":"5","author":"M Marquie","year":"2017","unstructured":"Marquie M, Verwer EE, Meltzer AC, Kim SJW, Aguero C, Gonzalez J, Makaretz SJ, Siao Tick Chong M, Ramanan P, Amaral AC, Normandin MD, Vanderburg CR, Gomperts SN, Johnson KA, Frosch MP, Gomez-Isla T (2017) Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson\u2019s case. Acta Neuropathol Commun 5:75","journal-title":"Acta Neuropathol Commun"},{"key":"2522_CR175","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1002\/mds.22680","volume":"24","author":"WR Martin","year":"2009","unstructured":"Martin WR, Wieler M, Gee M, Camicioli R (2009) Temporal lobe changes in early, untreated Parkinson\u2019s disease. Mov Disord 24:1949\u20131954","journal-title":"Mov Disord"},{"key":"2522_CR176","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000464322","volume":"77","author":"K Mashima","year":"2017","unstructured":"Mashima K, Ito D, Kameyama M, Osada T, Tabuchi H, Nihei Y, Yoshizaki T, Noguchi E, Tanikawa M, Iizuka T, Date Y, Ogata Y, Nakahara T, Iwabuchi Y, Jinzaki M, Murakami K, Suzuki N (2017) Extremely low prevalence of amyloid positron emission tomography positivity in Parkinson\u2019s disease without dementia. Eur Neurol 77:231\u2013237","journal-title":"Eur Neurol"},{"key":"2522_CR177","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1600-0404.2007.00838.x","volume":"116","author":"H Matsui","year":"2007","unstructured":"Matsui H, Nishinaka K, Oda M, Niikawa H, Kubori T, Udaka F (2007) Dementia in Parkinson\u2019s disease: diffusion tensor imaging. Acta Neurol Scand 116:177\u2013181","journal-title":"Acta Neurol Scand"},{"key":"2522_CR178","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s004010051064","volume":"98","author":"PM Mattila","year":"1999","unstructured":"Mattila PM, Rinne JO, Helenius H, Roytta M (1999) Neuritic degeneration in the hippocampus and amygdala in Parkinson\u2019s disease in relation to Alzheimer pathology. Acta Neuropathol 98:157\u2013164","journal-title":"Acta Neuropathol"},{"key":"2522_CR179","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s004019900168","volume":"100","author":"PM Mattila","year":"2000","unstructured":"Mattila PM, Rinne JO, Helenius H, Dickson DW, R\u00f6ytt\u00e4 M (2000) Alpha-synuclein-immunoreactive cortical lewy bodies are associated with cognitive impairment in Parkinson\u2019s disease. Acta Neuropathol 100:285\u2013290","journal-title":"Acta Neuropathol"},{"key":"2522_CR180","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/jnnp-2011-300828","volume":"83","author":"TR Melzer","year":"2012","unstructured":"Melzer TR, Watts R, MacAskill MR, Pitcher TL, Livingston L, Keenan RJ, Dalrymple-Alford JC, Anderson TJ (2012) Grey matter atrophy in cognitively impaired Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 83:188\u2013194","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2522_CR181","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1212\/WNL.0b013e3182929f62","volume":"80","author":"TR Melzer","year":"2013","unstructured":"Melzer TR, Watts R, MacAskill MR, Pitcher TL, Livingston L, Keenan RJ, Dalrymple-Alford JC, Anderson TJ (2013) White matter microstructure deteriorates across cognitive stages in Parkinson disease. Neurology 80:1841\u20131849","journal-title":"Neurology"},{"key":"2522_CR182","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3389\/fneur.2019.00391","volume":"10","author":"TR Melzer","year":"2019","unstructured":"Melzer TR, Stark MR, Keenan RJ, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Grenfell S, Horne KL, Young BN, Pascoe MJ, Almuqbel MM, Wang J, Marsh SH, Miller DH, Dalrymple-Alford JC, Anderson TJ (2019) Beta amyloid deposition is not associated with cognitive impairment in Parkinson\u2019s disease. Front Neurol 10:391","journal-title":"Front Neurol"},{"key":"2522_CR183","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s11682-018-9922-0","volume":"13","author":"AS Mihaescu","year":"2019","unstructured":"Mihaescu AS, Masellis M, Graff-Guerrero A, Kim J, Criaud M, Cho SS, Ghadery C, Valli M, Strafella AP (2019) Brain degeneration in Parkinson\u2019s disease patients with cognitive decline: a coordinate-based meta-analysis. Brain Imaging Behav 13:1021\u20131034","journal-title":"Brain Imaging Behav"},{"key":"2522_CR184","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/brain\/awp280","volume":"133","author":"J Molano","year":"2010","unstructured":"Molano J, Boeve B, Ferman T, Smith G, Parisi J, Dickson D, Knopman D, Graff-Radford N, Geda Y, Lucas J, Kantarci K, Shiung M, Jack C, Silber M, Pankratz VS, Petersen R (2010) Mild cognitive impairment associated with limbic and neocortical lewy body disease: a clinicopathological study. Brain 133:540\u2013556","journal-title":"Brain"},{"key":"2522_CR185","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s00415-018-8800-4","volume":"265","author":"R Monastero","year":"2018","unstructured":"Monastero R, Cicero CE, Baschi R, Dav\u00ec M, Luca A, Restivo V, Zangara C, Fierro B, Zappia M, Nicoletti A (2018) Mild cognitive impairment in Parkinson\u2019s disease: the Parkinson\u2019s disease cognitive study (PACOS). J Neurol 265:1050\u20131058","journal-title":"J Neurol"},{"key":"2522_CR186","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/bs.pbr.2022.01.008","volume":"269","author":"L Montaser-Kouhsari","year":"2022","unstructured":"Montaser-Kouhsari L, Young CB, Poston KL (2022) Neuroimaging approaches to cognition in Parkinson\u2019s disease. Prog Brain Res 269:257\u2013286","journal-title":"Prog Brain Res"},{"key":"2522_CR187","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/metabo10100380","volume":"10","author":"S Na","year":"2020","unstructured":"Na S, Jeong H, Park JS, Chung YA, Song IU (2020) The impact of amyloid-beta positivity with 18F-florbetaben PET on neuropsychological aspects in Parkinson\u2019s disease dementia. Metabolites 10:380","journal-title":"Metabolites"},{"key":"2522_CR188","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","volume":"114","author":"H Nakashima-Yasuda","year":"2007","unstructured":"Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, Arnold SE, Siderowf A, Grossman M, Leverenz JB, Woltjer R, Lopez OL, Hamilton R, Tsuang DW, Galasko D, Masliah E, Kaye J, Clark CM, Montine TJ, Lee VM, Trojanowski JQ (2007) Co-morbidity of TDP-43 proteinopathy in lewy body related diseases. Acta Neuropathol 114:221\u2013229","journal-title":"Acta Neuropathol"},{"key":"2522_CR189","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00415-009-5324-y","volume":"257","author":"PT Nelson","year":"2010","unstructured":"Nelson PT, Jicha GA, Kryscio RJ, Abner EL, Schmitt FA, Cooper G, Xu LO, Smith CD, Markesbery WR (2010) Low sensitivity in clinical diagnoses of dementia with lewy bodies. J Neurol 257:359\u2013366","journal-title":"J Neurol"},{"key":"2522_CR190","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","volume":"71","author":"PT Nelson","year":"2012","unstructured":"Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, Hyman BT, Iwatsubo T, Jellinger KA, Jicha GA, K\u00f6vari E, Kukull WA, Leverenz JB, Love S, Mackenzie IR, Mann DM, Masliah E, McKee AC, Montine TJ, Morris JC, Schneider JA, Sonnen JA, Thal DR, Trojanowski JQ, Troncoso JC, Wisniewski T, Woltjer RL, Beach TG (2012) Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol 71:362\u2013381","journal-title":"J Neuropathol Exp Neurol"},{"key":"2522_CR191","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"E Nichols","year":"2019","unstructured":"Nichols E, Collaborators GD (2019) Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 18:88\u2013106","journal-title":"Lancet Neurol"},{"key":"2522_CR192","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fnagi.2019.00021","volume":"11","author":"A Nicoletti","year":"2019","unstructured":"Nicoletti A, Luca A, Baschi R, Cicero CE, Mostile G, Dav\u00ec M, Pilati L, Restivo V, Zappia M, Monastero R (2019) Incidence of mild cognitive impairment and dementia in Parkinson\u2019s disease: the Parkinson\u2019s disease cognitive impairment study. Front Aging Neurosci 11:21","journal-title":"Front Aging Neurosci"},{"key":"2522_CR193","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3233\/JPD-202496","volume":"11","author":"YS Oh","year":"2021","unstructured":"Oh YS, Yoo SW, Lyoo CH, Yoo JY, Yoon H, Ha S, Lee KS, Kim JS (2021) The association of beta-amyloid with cognition and striatal dopamine in early, non-demented Parkinson\u2019s disease. J Parkinsons Dis 11:605\u2013613","journal-title":"J Parkinsons Dis"},{"key":"2522_CR194","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1212\/WNL.0000000000001020","volume":"83","author":"KT Olde Dubbelink","year":"2014","unstructured":"Olde Dubbelink KT, Schoonheim MM, Deijen JB, Twisk JW, Barkhof F, Berendse HW (2014) Functional connectivity and cognitive decline over 3 years in Parkinson disease. Neurology 83:2046\u20132053","journal-title":"Neurology"},{"key":"2522_CR195","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.parkreldis.2014.12.011","volume":"21","author":"LP Oosterveld","year":"2015","unstructured":"Oosterveld LP, Allen JC Jr, Reinoso G, Seah SH, Tay KY, Au WL, Tan LC (2015) Prognostic factors for early mortality in Parkinson\u2019s disease. Parkinsonism Relat Disord 21:226\u2013230","journal-title":"Parkinsonism Relat Disord"},{"key":"2522_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2021.111273","volume":"312","author":"C Owens-Walton","year":"2021","unstructured":"Owens-Walton C, Jakabek D, Power BD, Walterfang M, Hall S, van Westen D, Looi JCL, Shaw M, Hansson O (2021) Structural and functional neuroimaging changes associated with cognitive impairment and dementia in Parkinson\u2019s disease. Psychiatry Res Neuroimaging 312:111273","journal-title":"Psychiatry Res Neuroimaging"},{"key":"2522_CR197","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/ejn.15640","volume":"55","author":"C Owens-Walton","year":"2022","unstructured":"Owens-Walton C, Adamson C, Walterfang M, Hall S, van Westen D, Hansson O, Shaw M, Looi JCL (2022) Midsagittal corpus callosal thickness and cognitive impairment in Parkinson\u2019s disease. Eur J Neurosci 55:1859\u20131872","journal-title":"Eur J Neurosci"},{"key":"2522_CR198","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3233\/JAD-190323","volume":"70","author":"G Palermo","year":"2019","unstructured":"Palermo G, Tommasini L, Aghakhanyan G, Frosini D, Giuntini M, Tognoni G, Bonuccelli U, Volterrani D, Ceravolo R (2019) Clinical correlates of cerebral amyloid deposition in Parkinson\u2019s disease dementia: evidence from a PET study. J Alzheimers Dis 70:597\u2013609","journal-title":"J Alzheimers Dis"},{"key":"2522_CR283","doi-asserted-by":"crossref","unstructured":"Pan C, Li Y, Ren J, Li L, Huang P, Xu P, Zhang L, Zhang W, Zhang MM, Chen J, Liu W (2022) Characterizing mild cognitive impairment in prodromal Parkinson's disease: A community-based study in China. CNS Neurosci Ther 28:259-268","DOI":"10.1111\/cns.13766"},{"key":"2522_CR199","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10072-012-1250-3","volume":"34","author":"PL Pan","year":"2013","unstructured":"Pan PL, Shi HC, Zhong JG, Xiao PR, Shen Y, Wu LJ, Song YY, He GX, Li HL (2013) Gray matter atrophy in Parkinson\u2019s disease with dementia: evidence from meta-analysis of voxel-based morphometry studies. Neurol Sci 34:613\u2013619","journal-title":"Neurol Sci"},{"key":"2522_CR200","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jns.2015.03.046","volume":"353","author":"HE Park","year":"2015","unstructured":"Park HE, Park IS, Oh YS, Yang DW, Lee KS, Choi HS, Ahn KJ, Kim JS (2015) Subcortical whiter matter hyperintensities within the cholinergic pathways of patients with dementia and parkinsonism. J Neurol Sci 353:44\u201348","journal-title":"J Neurol Sci"},{"key":"2522_CR201","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.20321","volume":"57","author":"L Parkkinen","year":"2005","unstructured":"Parkkinen L, Kauppinen T, Pirttil\u00e3 T, Autere JM, Alafuzoff I (2005) Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann Neurol 57:82\u201391","journal-title":"Ann Neurol"},{"key":"2522_CR202","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.parkreldis.2016.07.008","volume":"31","author":"GM Peavy","year":"2016","unstructured":"Peavy GM, Edland SD, Toole BM, Hansen LA, Galasko DR, Mayo AM (2016) Phenotypic differences based on staging of Alzheimer\u2019s neuropathology in autopsy-confirmed dementia with lewy bodies. Parkinsonism Relat Disord 31:72\u201378","journal-title":"Parkinsonism Relat Disord"},{"key":"2522_CR203","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1212\/WNL.0000000000003634","volume":"88","author":"KF Pedersen","year":"2017","unstructured":"Pedersen KF, Larsen JP, Tysnes OB, Alves G (2017) Natural course of mild cognitive impairment in Parkinson disease: a 5-year population-based study. Neurology 88:767\u2013774","journal-title":"Neurology"},{"key":"2522_CR204","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1212\/WNL.0000000000000483","volume":"82","author":"JB Pereira","year":"2014","unstructured":"Pereira JB, Svenningsson P, Weintraub D, Br\u00f8nnick K, Lebedev A, Westman E, Aarsland D (2014) Initial cognitive decline is associated with cortical thinning in early Parkinson disease. Neurology 82:2017\u20132025","journal-title":"Neurology"},{"key":"2522_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104831","volume":"139","author":"JB Pereira","year":"2020","unstructured":"Pereira JB, Hall S, Jalakas M, Grothe MJ, Strandberg O, Stomrud E, Westman E, van Westen D, Hansson O (2020) Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson\u2019s disease. Neurobiol Dis 139:104831","journal-title":"Neurobiol Dis"},{"key":"2522_CR206","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jalz.2011.09.230","volume":"8","author":"F Perez","year":"2012","unstructured":"Perez F, Helmer C, Foubert-Samier A, Auriacombe S, Dartigues JF, Tison F (2012) Risk of dementia in an elderly population of Parkinson\u2019s disease patients: a 15-year population-based study. Alzheimers Dement 8:463\u2013469","journal-title":"Alzheimers Dement"},{"key":"2522_CR207","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1001\/archneurol.2009.266","volume":"66","author":"RC Petersen","year":"2009","unstructured":"Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, Smith GE, Jack CR Jr (2009) Mild cognitive impairment: ten years later. Arch Neurol 66:1447\u20131455","journal-title":"Arch Neurol"},{"key":"2522_CR208","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1212\/WNL.0b013e3182698d4a","volume":"79","author":"M Petrou","year":"2012","unstructured":"Petrou M, Bohnen NI, Muller ML, Koeppe RA, Albin RL, Frey KA (2012) Abeta-amyloid deposition in patients with Parkinson disease at risk for development of dementia. Neurology 79:1161\u20131167","journal-title":"Neurology"},{"key":"2522_CR209","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/mds.26191","volume":"30","author":"M Petrou","year":"2015","unstructured":"Petrou M, Dwamena BA, Foerster BR, MacEachern MP, Bohnen NI, Muller ML, Albin RL, Frey KA (2015) Amyloid deposition in Parkinson\u2019s disease and cognitive impairment: a systematic review. Mov Disord 30:928\u2013935","journal-title":"Mov Disord"},{"key":"2522_CR210","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.neurobiolaging.2004.10.006","volume":"26","author":"O Pletnikova","year":"2005","unstructured":"Pletnikova O, West N, Lee MK, Rudow GL, Skolasky RL, Dawson TM, Marsh L, Troncoso JC (2005) Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in lewy body diseases. Neurobiol Aging 26:1183\u20131192","journal-title":"Neurobiol Aging"},{"key":"2522_CR211","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/jnnp-2011-301874","volume":"83","author":"M Poletti","year":"2012","unstructured":"Poletti M, Frosini D, Pagni C, Baldacci F, Nicoletti V, Tognoni G, Lucetti C, Del Dotto P, Ceravolo R, Bonuccelli U (2012) Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 83:601\u2013606","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2522_CR212","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601","journal-title":"Mov Disord"},{"key":"2522_CR213","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1212\/WNL.0000000000012444","volume":"97","author":"J Prasuhn","year":"2021","unstructured":"Prasuhn J, Prasuhn M, Fellbrich A, Strautz R, Lemmer F, Dreischmeier S, Kasten M, M\u00fcnte TF, Hanssen H, Heldmann M, Br\u00fcggemann N (2021) Association of locus coeruleus and substantia nigra pathology with cognitive and motor functions in patients with Parkinson disease. Neurology 97:e1007\u2013e1016","journal-title":"Neurology"},{"key":"2522_CR214","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1002\/mds.28115","volume":"35","author":"R Purri","year":"2020","unstructured":"Purri R, Brennan L, Rick J, Xie SX, Deck BL, Chahine LM, Dahodwala N, Chen-Plotkin A, Duda JE, Morley JF, Akhtar RS, Trojanowski JQ, Siderowf A, Weintraub D (2020) Subjective cognitive complaint in Parkinson\u2019s disease patients with normal cognition: canary in the coal mine? Mov Disord 35:1618\u20131625","journal-title":"Mov Disord"},{"key":"2522_CR284","doi-asserted-by":"crossref","unstructured":"Qin Q, Wan H, Wang D, Li J, Yang Q, Zhao J, Xue Z (2022) Effect of cerebral microbleeds on cognitive function and quality of life in Parkinson disease. Med Sci Monit 28:e935026","DOI":"10.12659\/MSM.935026"},{"key":"2522_CR215","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/brain\/awx310","volume":"141","author":"NJ Ray","year":"2018","unstructured":"Ray NJ, Bradburn S, Murgatroyd C, Toseeb U, Mir P, Kountouriotis GK, Teipel SJ, Grothe MJ (2018) In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson\u2019s disease. Brain 141:165\u2013176","journal-title":"Brain"},{"key":"2522_CR216","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.parkreldis.2008.02.007","volume":"15","author":"I Rektor","year":"2009","unstructured":"Rektor I, Goldemund D, Sheardov\u00e3 K, Rektorov\u00e3 I, Mich\u00e3lkov\u00e3 Z, Dufek M (2009) Vascular pathology in patients with idiopathic Parkinson\u2019s disease. Parkinsonism Relat Disord 15:24\u201329","journal-title":"Parkinsonism Relat Disord"},{"key":"2522_CR217","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187939","volume":"13","author":"I Rektor","year":"2018","unstructured":"Rektor I, Sv\u00e1tkov\u00e1 A, Vojt\u00ed\u0161ek L, Zikmundov\u00e1 I, Van\u00edcek J, Kir\u00e1ly A, Szab\u00f3 N (2018) White matter alterations in Parkinson\u2019s disease with normal cognition precede grey matter atrophy. PLoS One 13:e0187939","journal-title":"PLoS One"},{"key":"2522_CR218","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000334765","volume":"10","author":"I Rektorova","year":"2012","unstructured":"Rektorova I, Krajcovicova L, Marecek R, Mikl M (2012) Default mode network and extrastriate visual resting state network in patients with Parkinson\u2019s disease dementia. Neurodegener Dis 10:232\u2013237","journal-title":"Neurodegener Dis"},{"key":"2522_CR219","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cger.2013.07.003","volume":"29","author":"R Roberts","year":"2013","unstructured":"Roberts R, Knopman DS (2013) Classification and epidemiology of MCI. Clin Geriatr Med 29:753\u2013772","journal-title":"Clin Geriatr Med"},{"key":"2522_CR220","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.851788","volume":"14","author":"S Rogozinski","year":"2022","unstructured":"Rogozinski S, Klietz M, Respondek G, Oertel WH, Grothe MJ, Pereira JB, H\u00f6glinger GU (2022) Reduction in volume of nucleus basalis of Meynert is specific to Parkinson\u2019s disease and progressive supranuclear palsy but not to multiple system atrophy. Front Aging Neurosci 14:851788","journal-title":"Front Aging Neurosci"},{"key":"2522_CR221","first-page":"469","volume-title":"Oxford textbook of old age psychiatry 2e","author":"A Rongve","year":"2013","unstructured":"Rongve A, Aarsland D (2013) Dementia in Parkinson\u2019s disease and dementia with lewy bodies. In: Dening T, Thomas A (eds) Oxford textbook of old age psychiatry 2e. Oxford Univ. Press, Oxford, pp 469\u2013478"},{"key":"2522_CR222","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.108985","volume":"208","author":"S Roshanbin","year":"2022","unstructured":"Roshanbin S, Xiong M, Hultqvist G, S\u00f6derberg L, Zachrisson O, Meier S, Ekmark-Lew\u00e9n S, Bergstr\u00f6m J, Ingelsson M, Sehlin D, Syv\u00e4nen S (2022) In vivo imaging of alpha-synuclein with antibody-based PET. Neuropharmacology 208:108985","journal-title":"Neuropharmacology"},{"key":"2522_CR223","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/nan.12294","volume":"42","author":"C Ruffmann","year":"2016","unstructured":"Ruffmann C, Calboli FC, Bravi I, Gveric D, Curry LK, de Smith A, Pavlou S, Buxton JL, Blakemore AI, Takousis P, Molloy S, Piccini P, Dexter DT, Roncaroli F, Gentleman SM, Middleton LT (2016) Cortical lewy bodies and abeta burden are associated with prevalence and timing of dementia in lewy body diseases. Neuropathol Appl Neurobiol 42:436\u2013450","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2522_CR224","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/WAD.0b013e31819c5ef4","volume":"23","author":"MN Sabbagh","year":"2009","unstructured":"Sabbagh MN, Adler CH, Lahti TJ, Connor DJ, Vedders L, Peterson LK, Caviness JN, Shill HA, Sue LI, Ziabreva I, Perry E, Ballard CG, Aarsland D, Walker DG, Beach TG (2009) Parkinson disease with dementia: comparing patients with and without Alzheimer pathology. Alzheimer Dis Assoc Disord 23:295\u2013297","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2522_CR225","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.nbd.2018.11.001","volume":"124","author":"F Sampedro","year":"2019","unstructured":"Sampedro F, Marin-Lahoz J, Martinez-Horta S, Pagonabarraga J, Kulisevsky J (2019) Dopaminergic degeneration induces early posterior cortical thinning in Parkinson\u2019s disease. Neurobiol Dis 124:29\u201335","journal-title":"Neurobiol Dis"},{"key":"2522_CR226","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.136424","volume":"769","author":"T Sang","year":"2022","unstructured":"Sang T, He J, Wang J, Zhang C, Zhou W, Zeng Q, Yuan Y, Yu L, Feng Y (2022) Alterations in white matter fiber in Parkinson disease across different cognitive stages. Neurosci Lett 769:136424","journal-title":"Neurosci Lett"},{"key":"2522_CR227","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1007\/s00415-020-09863-8","volume":"268","author":"E Sarasso","year":"2021","unstructured":"Sarasso E, Agosta F, Piramide N, Filippi M (2021) Progression of grey and white matter brain damage in Parkinson\u2019s disease: a critical review of structural MRI literature. J Neurol 268:3144\u20133179","journal-title":"J Neurol"},{"key":"2522_CR228","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.parkreldis.2019.04.020","volume":"65","author":"D Saredakis","year":"2019","unstructured":"Saredakis D, Collins-Praino LE, Gutteridge DS, Stephan BCM, Keage HAD (2019) Conversion to MCI and dementia in Parkinson\u2019s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 65:20\u201331","journal-title":"Parkinsonism Relat Disord"},{"key":"2522_CR229","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fneur.2020.00047","volume":"11","author":"S Sasikumar","year":"2020","unstructured":"Sasikumar S, Strafella AP (2020) Imaging mild cognitive impairment and dementia in Parkinson\u2019s disease. Front Neurol 11:47","journal-title":"Front Neurol"},{"key":"2522_CR230","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/mds.28864","volume":"37","author":"PG Scamarcia","year":"2022","unstructured":"Scamarcia PG, Agosta F, Spinelli EG, Basaia S, Stojkovic T, Stankovic I, Sarasso E, Canu E, Markovic V, Petrovic I, Stefanova E, Pagani E, Kostic VS, Filippi M (2022) Longitudinal white matter damage evolution in Parkinson\u2019s disease. Mov Disord 37:315\u2013324","journal-title":"Mov Disord"},{"key":"2522_CR231","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1093\/brain\/aws234","volume":"135","author":"JA Schneider","year":"2012","unstructured":"Schneider JA, Arvanitakis Z, Yu L, Boyle PA, Leurgans SE, Bennett DA (2012) Cognitive impairment, decline and fluctuations in older community-dwelling subjects with lewy bodies. Brain 135:3005\u20133014","journal-title":"Brain"},{"key":"2522_CR232","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/jnnp.69.3.308","volume":"69","author":"A Schrag","year":"2000","unstructured":"Schrag A, Jahanshahi M, Quinn N (2000) What contributes to quality of life in patients with Parkinson\u2019s disease? J Neurol Neurosurg Psychiatry 69:308\u2013312","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2522_CR233","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","volume":"16","author":"A Schrag","year":"2017","unstructured":"Schrag A, Siddiqui UF, Anastasiou Z, Weintraub D, Schott JM (2017) Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson\u2019s disease: a cohort study. Lancet Neurol 16:66\u201375","journal-title":"Lancet Neurol"},{"key":"2522_CR234","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/brain\/awy072","volume":"141","author":"J Schulz","year":"2018","unstructured":"Schulz J, Pagano G, Fern\u00e1ndez Bonfante JA, Wilson H, Politis M (2018) Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson\u2019s disease. Brain 141:1501\u20131516","journal-title":"Brain"},{"key":"2522_CR235","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","volume":"120","author":"WJ Schulz-Schaeffer","year":"2010","unstructured":"Schulz-Schaeffer WJ (2010) The synaptic pathology of alpha-synuclein aggregation in dementia with lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia. Acta Neuropathol 120:131\u2013143","journal-title":"Acta Neuropathol"},{"key":"2522_CR236","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1148\/radiol.12111280","volume":"263","author":"TM Seibert","year":"2012","unstructured":"Seibert TM, Murphy EA, Kaestner EJ, Brewer JB (2012) Interregional correlations in Parkinson disease and Parkinson-related dementia with resting functional MR imaging. Radiology 263:226\u2013234","journal-title":"Radiology"},{"key":"2522_CR237","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/brain\/awp234","volume":"132","author":"M Selikhova","year":"2009","unstructured":"Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ (2009) A clinico-pathological study of subtypes in Parkinson\u2019s disease. Brain 132:2947\u20132957","journal-title":"Brain"},{"key":"2522_CR238","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.120077","volume":"432","author":"ESC Severiano","year":"2022","unstructured":"Severiano ESC, Alarc\u00e3o J, Pav\u00e3o Martins I, Ferreira JJ (2022) Frequency of dementia in Parkinson\u2019s disease: a systematic review and meta-analysis. J Neurol Sci 432:120077","journal-title":"J Neurol Sci"},{"key":"2522_CR239","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/mds.26369","volume":"31","author":"N Shah","year":"2016","unstructured":"Shah N, Frey KA, Muller ML, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Albin RL, Bohnen NI (2016) Striatal and cortical beta-amyloidopathy and cognition in Parkinson\u2019s disease. Mov Disord 31:111\u2013117","journal-title":"Mov Disord"},{"key":"2522_CR240","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/mds.26051","volume":"29","author":"FJ Siepel","year":"2014","unstructured":"Siepel FJ, Bronnick KS, Booij J, Ravina BM, Lebedev AV, Pereira JB, Gruner R, Aarsland D (2014) Cognitive executive impairment and dopaminergic deficits in de novo Parkinson\u2019s disease. Mov Disord 29:1802\u20131808","journal-title":"Mov Disord"},{"key":"2522_CR241","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/nan.12308","volume":"42","author":"M Sierra","year":"2016","unstructured":"Sierra M, Gelpi E, Marti MJ, Compta Y (2016) Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the lewy body disorders spectrum. Neuropathol Appl Neurobiol 42:451\u2013462","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2522_CR242","first-page":"1234","volume":"90","author":"C Smith","year":"2019","unstructured":"Smith C, Malek N, Grosset K, Cullen B, Gentleman S, Grosset DG (2019) Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry 90:1234\u20131243","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2522_CR243","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1038\/s41598-018-23041-x","volume":"8","author":"R Smith","year":"2018","unstructured":"Smith R, Sch\u00f6ll M, Londos E, Ohlsson T, Hansson O (2018) (18)F-AV-1451 in Parkinson\u2019s disease with and without dementia and in dementia with lewy bodies. Sci Rep 8:4717","journal-title":"Sci Rep"},{"key":"2522_CR244","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1750-3639.2009.00371.x","volume":"20","author":"JA Sonnen","year":"2010","unstructured":"Sonnen JA, Postupna N, Larson EB, Crane PK, Rose SE, Montine KS, Leverenz JB, Montine TJ (2010) Pathologic correlates of dementia in individuals with lewy body disease. Brain Pathol 20:654\u2013659","journal-title":"Brain Pathol"},{"key":"2522_CR285","doi-asserted-by":"crossref","unstructured":"Speelberg DHB, Janssen Daalen JM, Bloem BR, Gagnon JF, Post B, Darweesh SKL (2022) Prodromal cognitive deficits and the risk of subsequent Parkinson's disease. Brain Sci 12:199","DOI":"10.3390\/brainsci12020199"},{"key":"2522_CR245","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM (2017) Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci 18:101\u2013113","journal-title":"Nat Rev Neurosci"},{"key":"2522_CR246","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28932","author":"AA Szwedo","year":"2022","unstructured":"Szwedo AA, Dalen I, Pedersen KF, Camacho M, B\u00e4ckstr\u00f6m D, Forsgren L, Tzoulis C, Winder-Rhodes S, Hudson G, Liu G, Scherzer CR, Lawson RA, Yarnall AJ, Williams-Gray CH, Macleod AD, Counsell CE, Tysnes OB, Alves G, Maple-Gr\u00f8dem J (2022) GBA and APOE impact cognitive decline in Parkinson\u2019s disease: a 10-year population-based study. Mov Disord. https:\/\/doi.org\/10.1002\/mds.28932","journal-title":"Mov Disord"},{"key":"2522_CR247","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/jnnp-2019-322042","volume":"91","author":"GEC Thomas","year":"2020","unstructured":"Thomas GEC, Leyland LA, Schrag AE, Lees AJ, Acosta-Cabronero J, Weil RS (2020) Brain iron deposition is linked with cognitive severity in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 91:418\u2013425","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2522_CR248","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3233\/JPD-212748","volume":"11","author":"BS Tilley","year":"2021","unstructured":"Tilley BS, Patel SR, Goldfinger MH, Pearce RKB, Gentleman SM (2021) Locus coeruleus pathology indicates a continuum of lewy body dementia. J Parkinsons Dis 11:1641\u20131650","journal-title":"J Parkinsons Dis"},{"key":"2522_CR249","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","volume":"131","author":"JB Toledo","year":"2016","unstructured":"Toledo JB, Gopal P, Raible K, Irwin DJ, Brettschneider J, Sedor S, Waits K, Boluda S, Grossman M, Van Deerlin VM, Lee EB, Arnold SE, Duda JE, Hurtig H, Lee VM, Adler CH, Beach TG, Trojanowski JQ (2016) Pathological alpha-synuclein distribution in subjects with coincident Alzheimer\u2019s and lewy body pathology. Acta Neuropathol 131:393\u2013409","journal-title":"Acta Neuropathol"},{"key":"2522_CR250","doi-asserted-by":"publisher","first-page":"7115","DOI":"10.1038\/s41598-021-86617-0","volume":"11","author":"HH Tsai","year":"2021","unstructured":"Tsai HH, Tsai LK, Lo YL, Lin CH (2021) Amyloid related cerebral microbleed and plasma Abeta40 are associated with cognitive decline in Parkinson\u2019s disease. Sci Rep 11:7115","journal-title":"Sci Rep"},{"key":"2522_CR251","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12868-021-00687-4","volume":"23","author":"H Tu","year":"2022","unstructured":"Tu H, Zhang ZW, Qiu L, Lin Y, Jiang M, Chia SY, Wei Y, Ng ASL, Reynolds R, Tan EK, Zeng L (2022) Increased expression of pathological markers in Parkinson\u2019s disease dementia post-mortem brains compared to dementia with lewy bodies. BMC Neurosci 23:3","journal-title":"BMC Neurosci"},{"key":"2522_CR252","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fnagi.2018.00325","volume":"10","author":"C Uribe","year":"2018","unstructured":"Uribe C, Segura B, Baggio HC, Campabadal A, Abos A, Compta Y, Marti MJ, Valldeoriola F, Bargallo N, Junque C (2018) Differential progression of regional hippocampal atrophy in aging and Parkinson\u2019s disease. Front Aging Neurosci 10:325","journal-title":"Front Aging Neurosci"},{"key":"2522_CR253","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.2741\/3594","volume":"14","author":"VN Uversky","year":"2009","unstructured":"Uversky VN (2009) Intrinsic disorder in proteins associated with neurodegenerative diseases. Front Biosci (Landmark Ed) 14:5188\u20135238","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2522_CR254","doi-asserted-by":"publisher","first-page":"9364","DOI":"10.1523\/JNEUROSCI.4787-13.2014","volume":"34","author":"KJ Vargas","year":"2014","unstructured":"Vargas KJ, Makani S, Davis T, Westphal CH, Castillo PE, Chandra SS (2014) Synucleins regulate the kinetics of synaptic vesicle endocytosis. J Neurosci 34:9364\u20139376","journal-title":"J Neurosci"},{"key":"2522_CR255","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neuint.2016.11.009","volume":"102","author":"Y Vermeiren","year":"2017","unstructured":"Vermeiren Y, De Deyn PP (2017) Targeting the norepinephrinergic system in Parkinson\u2019s disease and related disorders: the locus coeruleus story. Neurochem Int 102:22\u201332","journal-title":"Neurochem Int"},{"key":"2522_CR256","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/ana.410330506","volume":"33","author":"P Vermersch","year":"1993","unstructured":"Vermersch P, Delacourte A, Javoy-Agid F, Hauw JJ, Agid Y (1993) Dementia in Parkinson\u2019s disease: biochemical evidence for cortical involvement using the immunodetection of abnormal tau proteins. Ann Neurol 33:445\u2013450","journal-title":"Ann Neurol"},{"key":"2522_CR257","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2967\/jnumed.111.089730","volume":"52","author":"VL Villemagne","year":"2011","unstructured":"Villemagne VL, Ong K, Mulligan RS, Holl G, Pejoska S, Jones G, O\u2019Keefe G, Ackerman U, Tochon-Danguy H, Chan JG, Reininger CB, Fels L, Putz B, Rohde B, Masters CL, Rowe CC (2011) Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias. J Nucl Med 52:1210\u20131217","journal-title":"J Nucl Med"},{"key":"2522_CR258","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1192\/bjp.bp.114.148643","volume":"206","author":"Z Walker","year":"2015","unstructured":"Walker Z, Moreno E, Thomas A, Inglis F, Tabet N, Rainer M, Pizzolato G, Padovani A (2015) Clinical usefulness of dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible dementia with lewy bodies: randomised study. Br J Psychiatry 206:145\u2013152","journal-title":"Br J Psychiatry"},{"key":"2522_CR286","doi-asserted-by":"crossref","unstructured":"Wallace ER, Segerstrom SC, van Horne CG, Schmitt FA, Koehl LM (2022) Meta-analysis of cognition in Parkinson's disease mild cognitive impairment and dementia progression. Neuropsychol Rev 32:149-160","DOI":"10.1007\/s11065-021-09502-7"},{"key":"2522_CR287","doi-asserted-by":"crossref","unstructured":"Wan H, Wang G, Liu Q, Wang Y (2022) Effect of cerebral small vessel disease on cognitive impairment in Parkinson's disease: a systematic review and meta-analysis. Ann Transl Med 10:288","DOI":"10.21037\/atm-22-276"},{"key":"2522_CR259","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3389\/fphys.2018.01093","volume":"9","author":"Z Wang","year":"2018","unstructured":"Wang Z, Jia X, Chen H, Feng T, Wang H (2018) Abnormal spontaneous brain activity in early Parkinson\u2019s disease with mild cognitive impairment: a resting-state fMRI study. Front Physiol 9:1093","journal-title":"Front Physiol"},{"key":"2522_CR260","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.1016\/j.bmc.2017.10.010","volume":"25","author":"H Watanabe","year":"2017","unstructured":"Watanabe H, Ariyoshi T, Ozaki A, Ihara M, Ono M, Saji H (2017) Synthesis and biological evaluation of novel radioiodinated benzimidazole derivatives for imaging a-synuclein aggregates. Bioorg Med Chem 25:6398\u20136403","journal-title":"Bioorg Med Chem"},{"key":"2522_CR261","doi-asserted-by":"publisher","first-page":"fcz006","DOI":"10.1093\/braincomms\/fcz006","volume":"1","author":"RS Weil","year":"2019","unstructured":"Weil RS, Hsu JK, Darby RR, Soussand L, Fox MD (2019) Neuroimaging in Parkinson\u2019s disease dementia: connecting the dots. Brain Commun 1:fcz006","journal-title":"Brain Commun"},{"key":"2522_CR262","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1001\/archneurol.2011.725","volume":"68","author":"D Weintraub","year":"2011","unstructured":"Weintraub D, Doshi J, Koka D, Davatzikos C, Siderowf AD, Duda JE, Wolk DA, Moberg PJ, Xie SX, Clark CM (2011) Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol 68:1562\u20131568","journal-title":"Arch Neurol"},{"key":"2522_CR263","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/brain\/awr277","volume":"135","author":"D Weintraub","year":"2012","unstructured":"Weintraub D, Dietz N, Duda JE, Wolk DA, Doshi J, Xie SX, Davatzikos C, Clark CM, Siderowf A (2012) Alzheimer\u2019s disease pattern of brain atrophy predicts cognitive decline in Parkinson\u2019s disease. Brain 135:170\u2013180","journal-title":"Brain"},{"key":"2522_CR264","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.expneurol.2010.06.017","volume":"225","author":"J Wills","year":"2010","unstructured":"Wills J, Jones J, Haggerty T, Duka V, Joyce JN, Sidhu A (2010) Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson\u2019s disease brains with and without dementia. Exp Neurol 225:210\u2013218","journal-title":"Exp Neurol"},{"key":"2522_CR265","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/B978-0-12-819975-6.00010-8","volume":"179","author":"H Wilson","year":"2021","unstructured":"Wilson H, de Natale ER, Politis M (2021) Nucleus basalis of Meynert degeneration predicts cognitive impairment in Parkinson\u2019s disease. Handb Clin Neurol 179:189\u2013205","journal-title":"Handb Clin Neurol"},{"key":"2522_CR266","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1001\/jamaneurol.2017.3713","volume":"75","author":"JR Winer","year":"2018","unstructured":"Winer JR, Maass A, Pressman P, Stiver J, Schonhaut DR, Baker SL, Kramer J, Rabinovici GD, Jagust WJ (2018) Associations between tau, beta-amyloid, and cognition in Parkinson disease. JAMA Neurol 75:227\u2013235","journal-title":"JAMA Neurol"},{"key":"2522_CR267","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/bs.pbr.2022.01.015","volume":"269","author":"AH Wise","year":"2022","unstructured":"Wise AH, Alcalay RN (2022) Genetics of cognitive dysfunction in Parkinson\u2019s disease. Prog Brain Res 269:195\u2013226","journal-title":"Prog Brain Res"},{"key":"2522_CR268","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.parkreldis.2018.12.016","volume":"62","author":"AF Wolters","year":"2019","unstructured":"Wolters AF, van de Weijer SCF, Leentjens AFG, Duits AA, Jacobs HIL, Kuijf ML (2019) Resting-state fMRI in Parkinson\u2019s disease patients with cognitive impairment: a meta-analysis. Parkinsonism Relat Disord 62:16\u201327","journal-title":"Parkinsonism Relat Disord"},{"key":"2522_CR269","doi-asserted-by":"publisher","first-page":"15027","DOI":"10.1038\/npjparkd.2015.27","volume":"2","author":"KL Wood","year":"2016","unstructured":"Wood KL, Myall DJ, Livingston L, Melzer TR, Pitcher TL, MacAskill MR, Geurtsen GJ, Anderson TJ, Dalrymple-Alford JC (2016) Different PD-MCI criteria and risk of dementia in Parkinson\u2019s disease: 4-year longitudinal study. NPJ Parkinsons Dis 2:15027","journal-title":"NPJ Parkinsons Dis"},{"key":"2522_CR270","doi-asserted-by":"publisher","DOI":"10.1049\/syb2.1204'","author":"S Xie","year":"2022","unstructured":"Xie S, Yang J, Huang S, Fan Y, Xu T, He J, Guo J, Ji X, Wang Z, Li P, Chen J, Zhang Y (2022) Disrupted myelination network in the cingulate cortex of Parkinson\u2019s disease. IET Syst Biol. https:\/\/doi.org\/10.1049\/syb2.12043","journal-title":"IET Syst Biol"},{"key":"2522_CR271","doi-asserted-by":"publisher","first-page":"220","DOI":"10.21037\/qims.2019.10.17","volume":"10","author":"R Xu","year":"2020","unstructured":"Xu R, Hu X, Jiang X, Zhang Y, Wang J, Zeng X (2020) Longitudinal volume changes of hippocampal subfields and cognitive decline in Parkinson\u2019s disease. Quant Imaging Med Surg 10:220\u2013232","journal-title":"Quant Imaging Med Surg"},{"key":"2522_CR272","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1007\/s00415-016-8122-3","volume":"263","author":"Y Xu","year":"2016","unstructured":"Xu Y, Yang J, Hu X, Shang H (2016) Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson\u2019s disease. J Neurol 263:1178\u20131187","journal-title":"J Neurol"},{"key":"2522_CR273","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1212\/WNL.0000000000000066","volume":"82","author":"AJ Yarnall","year":"2014","unstructured":"Yarnall AJ, Breen DP, Duncan GW, Khoo TK, Coleman SY, Firbank MJ, Nombela C, Winder-Rhodes S, Evans JR, Rowe JB, Mollenhauer B, Kruse N, Hudson G, Chinnery PF, O\u2019Brien JT, Robbins TW, Wesnes K, Brooks DJ, Barker RA, Burn DJ (2014) Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology 82:308\u2013316","journal-title":"Neurology"},{"key":"2522_CR288","doi-asserted-by":"publisher","unstructured":"Ye R, O'Callaghan C, Rua C, Hezemans FH, Holland N, Malpetti M, Jones PS, Barker RA, Williams-Gray CH, Robbins TW, Passamonti L, Rowe J (2022) Locus coeruleus integrity from 7 T MRI relates to apathy and cognition in parkinsonian disorders. Mov Disord online May 16: https:\/\/doi.org\/10.1002\/mds.29072","DOI":"10.1002\/mds.29072"},{"key":"2522_CR274","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s11011-021-00689-5","volume":"36","author":"V Zaman","year":"2021","unstructured":"Zaman V, Shields DC, Shams R, Drasites KP, Matzelle D, Haque A, Banik NL (2021) Cellular and molecular pathophysiology in the progression of Parkinson\u2019s disease. Metab Brain Dis 36:815\u2013827","journal-title":"Metab Brain Dis"},{"key":"2522_CR275","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1136\/jnnp-2012-304126","volume":"84","author":"M Zarei","year":"2013","unstructured":"Zarei M, Ibarretxe-Bilbao N, Compta Y, Hough M, Junque C, Bargallo N, Tolosa E, Mart\u00ed MJ (2013) Cortical thinning is associated with disease stages and dementia in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 84:875\u2013881","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2522_CR276","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.parkreldis.2021.01.002","volume":"83","author":"P Zarifkar","year":"2021","unstructured":"Zarifkar P, Kim J, La C, Zhang K, YorkWilliams S, Levine TF, Tian L, Borghammer P, Poston KL (2021) Cognitive impairment in Parkinson\u2019s disease is associated with default mode network subsystem connectivity and cerebrospinal fluid A\u00df. Parkinsonism Relat Disord 83:71\u201378","journal-title":"Parkinsonism Relat Disord"},{"key":"2522_CR277","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.531993","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Burock MA (2020) Diffusion tensor imaging in Parkinson\u2019s disease and parkinsonian syndrome: a systematic review. Front Neurol 11:531993","journal-title":"Front Neurol"},{"key":"2522_CR278","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2019.111973","volume":"371","author":"D Zheng","year":"2019","unstructured":"Zheng D, Chen C, Song W, Yi Z, Zhao P, Zhong J, Dai Z, Shi H, Pan P (2019) Regional gray matter reductions associated with mild cognitive impairment in Parkinson\u2019s disease: a meta-analysis of voxel-based morphometry studies. Behav Brain Res 371:111973","journal-title":"Behav Brain Res"},{"key":"2522_CR279","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/cns.13188","volume":"26","author":"C Zhou","year":"2020","unstructured":"Zhou C, Guan XJ, Guo T, Zeng QL, Gao T, Huang PY, Xuan M, Gu QQ, Xu XJ, Zhang MM (2020) Progressive brain atrophy in Parkinson\u2019s disease patients who convert to mild cognitive impairment. CNS Neurosci Ther 26:117\u2013125","journal-title":"CNS Neurosci Ther"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-022-02522-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-022-02522-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-022-02522-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T07:55:57Z","timestamp":1727423757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-022-02522-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":288,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2522"],"URL":"https:\/\/doi.org\/10.1007\/s00702-022-02522-4","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,20]]},"assertion":[{"value":"30 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}